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SIGNIFICANCE AND OVERVIEW
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SIGNIFICANCE & OVERVIEW
Cancer remains among the leading causes of death worldwide. In 2008, the International
Agency for Research on Cancer (IARC) estimated the global risk of being diagnosed with cancer
before age 75 to be 21.2% and 16.5% for men and women respectively [1]. The IARC estimated
the risk of dying from cancer before age 75 to be 13.4% and 9.1% for men and women
respectively. The figures become even more daunting when we consider the statistics for
economically developed countries like the United States of America, where males under age 75
have a 33.5% risk of being diagnosed with cancer, while women in the same category have a
26.7% risk [1]. Why is it that despite intense and prolonged cancer research over the last
decades the incidence and mortality of cancer remains so high? Cancer, it turns out, is a
multifaceted disease with the ability to stem from and/or affect almost any cell in the body. And
with hundreds of trillions of cells in the human body [2], the real question becomes - why is the
rate of cancer so low?

In an excellent review of the disease [3, 4], Hanahan and Weinberg described six
features which a cell needs to acquire to become cancerous: (i) sustained stimulation of growth,
(ii) resistance to tumor suppressor mechanisms, (iii) evasion of cell death, (iv) replicative
immortality, (v) ability to activate angiogenesis and (vi) activation of metastasis and invasion. In a
recent update they added four features that have consistently been associated with
tumorigenesis: (a) evasion of immune destruction, (b) inflammation, (c) genomic instability and (d)
deregulation of cellular energetics (Figure 1). Thus, it is undeniable that our own bodies do an
enormous amount of work to ward of tumorigenesis and are extremely effective at doing so, at
least while we are young. After age 40, the incidence of cancer dramatically increases [5] (Figure
2), indicating age as one of the single highest risk factors for cancer. Unfortunately, unlike dietary
and environmental factors we are as yet unable to limit our exposure to age, so we must develop
a better understanding of the relationship between age and cancer.

Research performed in the last few years has revealed important roles for the spatial and
temporal organization of the genome on genome integrity and function [6, 7]. Alterations of
2
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Figure 2. Age‐specific incidence of invasive cancer in the US for the period of 1992 to 2008.
Data from the National Cancer Institute’s SEER (Surveillance and Epidemiology and End Results)
program.

A-type lamins, key structural components of the nucleus, have been implicated in the
maintenance of nuclear architecture and chromatin organization [7, 9]. Mutations in A-type lamins
have been associated with defects in a number of nuclear processes, including DNA replication
and repair, and gene transcription and silencing [10, 11]. In support of an important role for
nuclear organization in pathogenesis, mutations in A-type lamins are associated with a wide
variety of degenerative diseases which range from muscular dystrophies and lipodystrophies to
premature aging syndromes [12, 13]. In addition, alterations in the expression of A-type lamins
are associated with different cancers such as small cell lung carcinoma and gastrointestinal
neoplasms [14-17]. Despite the prevalent link between A-type lamins and disease, the molecular
mechanisms behind lamins-associated pathogenesis are poorly understood. Elucidation of these
mechanisms would provide insight into how nuclear organization affects genome function and
stability and the relationship between nuclear organization, cancer and other age-related
diseases.
4

SIGNIFICANCE & OVERVIEW
To advance the field, I have investigated the role of A-type lamins in the maintenance of
genomic stability in mammalian cells. I present data showing novel functions for A-type lamins in
the maintenance of the structure and nuclear distribution of telomeres, and the efficacy of the two
major pathways of DNA double strand breaks repair, non-homologous end-joining (NHEJ) and
homologous recombination (HR). Furthermore, I show that the mechanisms by which A-type
lamins contribute to NHEJ and HR are distinct. A-type lamins maintain post-translational
stabilization of 53BP1, which is an important NHEJ protein. In addition, A-type lamins maintain
HR by regulating transcription of BRCA1 and RAD51, two essential HR factors. Importantly, the
study of A-type lamins has led us to the discovery of a cysteine protease, cathepsin L, as a novel
regulator of 53BP1 and the retinoblastoma tumor suppressor proteins. These findings are
significant, because they reveal unexpected functions of A-type lamins and novel pathways that
affect genomic stability. Our findings represent an important advance in understanding how
nuclear organization affects genome function

5
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BACKGROUND

(i) Genomic instability and tumorigenesis
Normal cells are subject to strictly controlled signaling mechanisms which ensure
controlled growth, proliferation, and death if necessary. Tumors arise from cells that not only
escape these controls, but also acquire the ability to stimulate growth of new blood vessels for
nutrient supply, escape replicative mortality, and migrate from the primary site of formation to
invade other tissues [3, 4]. Genomic instability -abnormal alterations in the structure or sequence
of the genome- increases the likelihood of acquiring these characteristics [3]. In hereditary
cancers, it commonly results from defective DNA damage repair due to germline mutations in
DNA repair genes such as BRCA1, BRCA2 and WRN [18]. However, the cause of initial genomic
instability in non-hereditary (sporadic) cancers is much less clear. Prior to therapy, sporadic
cancers are not characterized by frequent mutations in DNA repair genes. Instead, the genomic
instability is speculated to arise from other factors such as oncogenic mutations of caretaker
genes like TP53 [18]. Defects in telomere biology and DNA damage repair are among the leading
causes of genomic instability in cancer and aging.

(ii)Telomeres
Semi-conservative

replication

of

DNA

presents

a

unique

problem

for

linear

chromosomes. Since DNA polymerase moves in a 5’ to 3’ direction and requires RNA primers to
begin synthesis, the very ends of the lagging strand DNA are not replicated (the “end replication
problem”) [19]. Thus, there is loss of genomic DNA with successive bouts of replication and cell
division [19]. The presence of telomeres, highly conserved specialized nucleoprotein structures
found at the end of linear chromosomes, helps to ameliorate this problem [20]. Telomeres serve a
number of essential functions on chromosomes: (i) they buffer loss of genomic DNA due to the
end replication problem, (ii) their specialized structure protects the ends of chromosomes from
nucleolytic processing, (iii) they distinguish the ends of linear chromosomes from DNA doublestrand breaks, and importantly (iv) they limit the replicative ability of the cell.
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Normal somatic cells undergo telomere attrition with each round of cell division [21, 22].
When telomeres reach a critically short length, proliferation is halted as cells enter senescence,
an irreversible state of cell cycle arrest [23, 24]. Cells that are able to bypass senescence
continue dividing until the telomeres become so short as to trigger a second crisis, which is
characterized by profound genomic instability that causes massive cell death[23]. Cancer cells
acquire immortality by activating telomere lengthening mechanisms. 80-90% of cancers
upregulate telomerase, a ribonucleoprotein enzymatic complex that is capable of performing de
novo telomere extension [25-29]. Other cancers activate alternative lengthening of telomeres
(ALT), a process which involves extension by recombination between telomere sister chromatids
[30-33]. Telomere maintenance allows cancer cells to survive crisis [34] and attain unlimited
replicative potential - immortalization [24, 35]. Inhibition of telomerase activity is under active
research as a potential anticancer therapy [36-38].

While the length of the telomere is extremely important for its function, its tertiary
structure is no less important. Human and mouse telomeres are composed of double stranded
DNA (dsDNA) 5’ to 3’ TTAGGG repeats, capped off by a G-rich 3’ overhang of single stranded
DNA [39]. The G-rich overhang folds back onto the dsDNA and invades its complementary base
pairing in a D-loop structure, forming a larger T-loop tertiary structure (Figure 3). Formation of the
T-loop is facilitated by the shelterin complex which is composed of six proteins: the dsDNA
binding TRF1 and TRF2, the ssDNA binding POT1, and the ancillary proteins TPP1, TIN2 and
Rap1 [20, 40]. TRF1 and TRF2 bind directly to TTAGGG repeats and are present in the complex
as homodimers. TPP1 and POT1 form a heterodimer with high affinity for the G-strand overhang,
while TIN2 tethers TPP1/POT1 to TRF1 and TRF2, contributing to the stabilization of the complex
[40-49]. All six proteins are necessary for maintenance of the tertiary structure, however TRF2
and TPP1-POT1 are notable for their role in preventing the telomeres from being recognized as
DNA breaks by the DNA damage repair pathway. Removal of TRF2 or TPP1-POT1 shunts
telomeres to the non-homologous end joining (NHEJ) DNA damage repair pathway [50, 51]. This
results in end-to-end fusion of chromosomes, which leads to massive genomic instability in the
8
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polymerase II [58, 59]. TERRAs are emerging as inhibitors of telomerase activity and have been
implicated in both the assembly of telomeric heterochromatin and regulation of telomere
replication. Upregulation of TERRAs in S. cerevisiae resulted in telomere elongation and was
associated with replication defects which resulted in increased sensitivity to hydroxyurea [60, 61].
Thus, the coordinated action of telomere length maintenance mechanisms and telomere binding
proteins is essential for preserving the role of telomeres in ensuring genomic stability.

(iii)The DNA damage response (DDR)
Cells are constantly subjected to DNA damage from exogenous factors such as UV
irradiation, and endogenous factors such as oxidative damage from metabolic processes,
replication errors or aberrant activation of nucleases [62]. In addition to accidental DNA damage,
some normal physiologic processes such as variable diversity and joining (VDJ) recombination
and class switch recombination (CSR) in developing lymphocytes, involve deliberate formation of
DNA breaks and require specific mechanisms of repair [63]. The presence of unrepaired doublestrand breaks (DSBs) can be especially deleterious as it can trigger cell cycle arrest or even cell
death when the damage is beyond repair [62]. Similarly, use of inappropriate repair mechanisms
can cause genomic instability due to loss of genomic material or chromosomal translocation[64].
To counter the assaults on genomic integrity, cells have developed a DNA damage response
pathway and a variety of specialized mechanisms for repair of DNA DSBs (Figure 4 and Table 1).

All organisms respond to DNA damage by launching the DNA damage response (DDR)
[65, 66]. The DDR can be considered a signal transduction pathway where damaged DNA is
detected by “sensors” that trigger the activation of a signaling cascade composed of protein
kinases of the PIKK family – ATM (Ataxia telangiectasia mutated) and ATR (Ataxia Telangiectasia
and Rad3 related) [67, 68]. The kinase cascade amplifies and transduces the initial DNA damage
signal and triggers activation of “effector” proteins that activate cell cycle arrest or repair the
damaged DNA. In mammalian cells, a DNA DSB is recognized by the MRN (Mre11/RAD51/Nbs1)
sensor complex, which recruits ATM to the damage site. Once recruited, ATM undergoes
10
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autophosphorylation and monomerization, and initiates the phosphorylation of a number of
substrates implicated in different aspects of DNA repair such as Nbs1, the histone variant H2AX,
and the tumor suppressor protein BRCA1. Additionally, ATM activates proteins involved in cell
cycle arrest such as p53 and Chk2. This is particularly essential as it ensures that damaged DNA
is repaired prior to DNA replication. Activation of the DDR results in repair of the DSB by either
homology directed repair or non-homologous end-joining. The repair process generally includes
processing of the end to remove damaged DNA, strand fill-in by DNA polymerases and finally
ligation of opposite ends of the break [62, 69]. The extent of DNA end-resection during
processing and the mechanism used for strand fill-in differ significantly between the two major
forms of DSB repair - homology directed repair and non-homologous end-joining.

Intentional DNA double-strand
breaks
•Variable diversity and joining
(V(D)J recombination)
•Class switch recombination

Accidental DNA double-strand breaks
•Exogenous damage (ionizing radiation etc.)
•Endogenous damage (oxidative free
radicals, replication errors, enzymatic action
etc.)

Non-homologous end joining
(NHEJ)
•Classic-NHEJ (C-NHEJ)

Homology directed repair
•Homologous recombination
(HR)

•Alternative NHEJ (A-NHEJ)

•Single strand annealing (SSA)

Repaired break

Repaired break

Figure 4. Mechanisms of DNA double strand break repair. Physiologic breaks such as those
induced during immune cell development processes like V(D)J recombination and class switch
recombination are targeted for repair by non‐homologous end joining (NHEJ). Pathologic DSBs
such as those occurring upon exposure to ionizing radiation, or free radical attack can be
targeted for repair by NHEJ or by homology directed repair (HDR) depending on the cell cycle
phase. As opposed to HR, NHEJ is error prone and likely to result in alterations in the genomic
sequence at the site of repair. Indiscriminate use of either HR or NHEJ can cause genomic
instability. Figure adapted from Lieber MR 2010 [63].
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Table 1. Various causes of DNA double‐strand breaks in eukaryotic cells. Adapted from Lieber
2010.
Causes of DNA Double Strand Breaks
Physiological

V(D)J recombination, induced by RAG1/2
Class switch recombination

Pathological

Ionizing radiation
Reactive oxygen species
Replication across a nick
Enzymatic action at fragile sites
Topoisomerase failures
Mechanical stress

(iv) Homology directed repair (HDR)
Homology directed repair occurs under diploid conditions such as during meiosis or S/G2
phases of mitotic cells. Of the three types of HDR mechanisms -homologous recombination,
single strand annealing and break-induced replication- homologous recombination is most
frequently used [70]. Homologous recombination (HR) is possible during S/G2 phases of the cell
cycle where DNA replication has produced sister chromatids to be used as templates for
recombination. In the event of a DSB, there is extensive end resection of one strand of the DNA
to reveal a 5’ - 3’ single strand overhang. ssDNA formed by end resectioning is coated with a
ssDNA binding protein complex, RPA, which removes secondary structures on the DNA strand.
Next, displacement of RPA on ssDNA by RAD51 forms the essential presynaptic filament, which
facilitates the search for regions of homology, strand invasion and subsequent strand fill in by
DNA polymerase [70-73]. The exact mechanism of DNA end resectioning in vertebrates remains
unclear and seems to involve a number of different nucleases [73]. Recent studies have identified
the mammalian protein CtIP as having an essential role in end resection, as depletion of CtIP
leads to severe inhibition of the formation of ssDNA [74-79]. The role of CtIP in end resection
relies on the ability of the phosphorylated form of the protein to interact not only with BRCA1,
12
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which facilitates its recruitment to DSB sites [80, 81], but also with Mre11, a DNA damage sensor
which possesses nuclease activity [73, 77, 82]. While the mechanism by which CtIP promotes
end-resection is unclear, its recruitment is proposed to be a “switch” which facilitates endresection of DSBs, in conjunction with MRN [79]. However the possibility remains that CtIP itself
has nucleolytic activity, as has been shown for the S. cerevisiae homolog Sae2 [73].

BRCA1 functions as a tumor suppressor and mutations in the gene are commonly
associated with breast and ovarian cancer [83-85]. The role of BRCA1 as a tumor suppressor
stems from its essential role in facilitating formation of ssDNA during homologous recombination
[86, 87]. BRCA1-deficient cells display significant reduction in the formation of ssDNA and
subsequent recruitment of ssDNA binding proteins such as RPA and RAD51. Recent reports
have established BRCA1 as a “competitor” against the NHEJ protein 53BP1 for DSB repair
substrate [88-91]. These studies showed that loss of BRCA1 was associated with decreased HR
and increased formation of aberrant chromosomal structures, and that this phenotype was
reversed by decreasing 53BP1. The authors speculated that in the absence of BRCA1, DSBs that
would normally be fixed by HR are retargeted for NHEJ by 53BP1, leading to ligation between
incompatible DSBs which result in aberrant chromosome structures [90]. Removing 53BP1 is
postulated to reduce this NHEJ pressure, which increases the competitive ability of HR. Thus,
53BP1-mediated NHEJ is a direct competitor of BRCA1-mediated HR. Activation of HR in the
absence of sister chromatids could result in recombination between homologous regions of nonsister chromatids, which could cause loss of heterozygosity, or chromosomal translocations if
non-allelic sequence templates are used [70]. Interestingly, Shibata A. et al. recently reported that
NHEJ is used as the first attempt for DSB repair even during the G2 phase of the cell cycle of
human fibroblasts [92]. The authors propose that components of THE NHEJ pathway are
preferentially recruited to DSBs, but in the event of structural complexities at the lesion, the NHEJ
proteins give way to HR.
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(v) Non‐homologous end joining (NHEJ)
NHEJ is dominant during G0/G1 and early S phase. It relies on ligation between DSB
ends that have undergone minimal processing [93]. Upon recognition of a DSB, the Ku70/Ku80
heterodimer encircles the DNA end and helps to recruit DNA-dependent protein kinase catalytic
subunit (DNA-PKcs), a member of the PIKK family of protein kinases. DNA-PKcs undergoes
autophosphorylation and phosphorylates a number of proteins at the break site [63, 94].
Recruitment of the DNA processing enzyme Artemis follows activation of DNA-PKcs kinase
activity. Artemis is important for the formation of 5’-phosphorylated ligatable DNA ends putatively
through it’s exo- and endonuclease activities [95-97]. Further processing such as gap-fill in by
DNA polymerases (μ and λ) might be required to prepare the DNA ends for ligation [63]. Once
compatible ends have been formed ligation occurs by a complex containing XRCC4, a ku
interacting protein, and the ligating enzyme DNA ligase IV. The ligation step is significantly
different from HR, as it requires neither significant end-resection nor homologous sequences for
strand fill-in by DNA polymerase.

The ku70/80 heterodimer can interact with and recruit nucleases, polymerases and the
ligase complex in any order [63]. This allows flexibility in the sequence of processing events at
the DSB site, with the result that a single DSB can yield different DNA sequences at the region of
ligation. For example, a break that is processed by a nuclease and then a polymerase will be
different from one that is processed by a nuclease and then a DNA ligase. Further diversity might
occur from recruitment of polymerase μ, which is capable of template-independent DNA
synthesis for strand fill-in. Thus, unlike HR, NHEJ is inherently associated with alterations of the
DNA sequence at the site of repair. While NHEJ is more error prone than HR it is essential not
only for the timely repair of pathogenic DSBs, but also for endogenous processes which involve
deliberate formation/repair of DSBs, such as class switch recombination (CSR) and variable
diversity and joining recombination (VDJ) in lymphocytes [98-100]. Mutations in NHEJ genes are
associated with increased radiosensitivity as well as immunodeficiency syndromes [101, 102].
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Along with this “classic” form of NHEJ (C-NHEJ), recent work has begun to demonstrate
the importance of a less understood pathway designated “alternative-NHEJ” (A-NHEJ) pathway
[93, 103, 104]. A-NHEJ is distinct from C-NHEJ in its requirement for short regions of
microhomology between ligatable ends of DNA [93, 105]. A-NHEJ relies on CtIP-mediated
resection of DNA to reveal short regions of homology, which then undergo ligation primarily
mediated by DNA ligase III [104, 106]. Unlike homologous recombination, DNA that is resected
during A-NHEJ does not undergo strand fill-in from a homologous sequence, so there is
permanent loss of DNA sequence, making it a potentially more deleterious pathway than C-NHEJ
or HR. In line with this idea, A-NHEJ was reported to play a primary role in the formation of
chromosomal translocations in mouse embryonic stem cells [103].

(vi) p53 Binding Protein 1 (53BP1)
53BP1 was initially discovered in 1994 in a yeast two-hybrid screen as a p53-interacting
protein [107]. Since its discovery it has been demonstrated to play significant roles in DSBs repair
pathways with a primary role in NHEJ of long-range DNA breaks and an indirect role as a
suppressor of other pathways of DSBs repair [108-112]. 53BP1 is necessary for efficient repair of
non-pathogenic “long-range” DSBs such as those that occur during V(D)J recombination or classswitch recombination in immune cell development and maturation [51, 98-100, 113]. Maturation of
the immune system B and T lymphocytes involves generation of DSBs by RAG1 and RAG2
endonucleases at recombination signal sequences on different gene segments (Variable,
Diversity and Joining). Ligation of the DSBs produces the heavy and light immunoglobulin chains
during maturation. 53BP1 was shown to be necessary for joining between distal (long-range)
sequences, but dispensable for short range end-joining. Consistent with these roles, 53BP1-/mice suffer a significant reduction in the formation of B & T cell lineage cells [100]. Similarly,
53BP1 is necessary for long range DSBs end joining which occurs in class switch recombination
during B cell activation, and also in the processing of telomeres that are rendered deprotected by
loss of the TRF2 shelterin complex component [51, 98]. The mechanism by which 53BP1
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promotes end-joining between distal DSBs is unclear, but thought to involve promotion of
synapsis, chromatin relaxation and possibly regulation of the mobility of DSBs [114, 115].

A number of unresolved questions remain regarding the role of 53BP1 in repair of
different forms of DNA DSBs. For example, 53BP1 is immediately recruited to DSBs induced by
ionizing radiation (IR), however loss of 53BP1 has only a mild effect on the repair of IR-induced
breaks. Furthermore, the necessity for 53BP1 seems to depend on the amount of DSBs that are
present, such that 53BP1 has a bigger impact on the repair of low levels of DSBs, putatively
through its ability to promote recruitment of the MRN complex (which then promotes ATM
recruitment) via binding of Rad50 to the BRCT domain of 53BP1 [111, 114, 116]. It is speculated
that high levels of IR-induced DSBs can sufficiently stimulate MRN recruitment and activation of
ATM, while low levels stimulate only a mild DDR, and thus require assistance from 53BP1 [114].
Recent work demonstrating a specific role for 53BP1 in late-repairing heterochromatic DSBs has
begun to shed light on these issues, showing why 53BP1 might only be required for repair of a
subset of IR-induces breaks. A.T. Noon and colleagues [114] demonstrated that 53BP1 promotes
localization of phosphorylated KAP-1 (pKAP-1, KRAB Associated Protein-1) at late repairing
heterochromatic DSBs that were induced by IR. pKAP-1 promotes repair of heterochromatic
DSBs by inhibiting the function of CHD3, an ATP dependent chromatin remodeling enzyme which
promotes nucleosome compaction [117]. Thus, 53BP1 plays a significant role in repair of breaks
in heterochromatic regions of the genome by affecting chromatin structure.

Recent work revealed that 53BP1 suppresses HR and A-NHEJ putatively by binding to
DSBs and inhibiting end-resection [90, 118]. Further work is required to clarify the exact
mechanism of inhibition; however the implication of 53BP1 in other repair pathways is exciting, as
it suggests novel approaches for cancer therapy. A number of elegant studies recently
demonstrated that loss of 53BP1 can reverse some of the phenotypes associated with BRCA1
deficiency [89-91]. In particular, cells double null for BRCA1 and 53BP1 exhibit a much lower
degree of genomic instability and have increased survival when treated with DNA damaging
16
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agents. These studies demonstrate that loss of 53BP1 is “synthetically viable” with BRCA1 loss
[88]. The current view is that loss of BRCA1 results in defective end-resection of DNA DSBs. In
this context, accumulation of 53BP1 at the breaks promotes NHEJ.

The interplay between 53BP1 and the HR pathway is functionally important, as it could
contribute to the development of resistance of BRCA1-mutated cancers to treatment with DNA
damaging agents. A major breakthrough in the treatment of BRCA1-mutant tumors was the
finding that these types of tumors are very sensitive to poly(ADP-ribose) polymerase inhibitors
(PARPi) [119, 120]. The targets of PARPi are PARP1 and the closely related PARP2 proteins,
which are activated at sites of DNA breaks to catalyze the formation of poly(ADP-ribose)
polymers both on themselves as well as other substrates [121-124]. Inhibition of PARP activity
hinders repair of single stranded DNA breaks, which are converted to DSBs if encountered by a
replication fork during DNA synthesis in S-phase. [120, 125]. Since DSBs are primarily repaired
by HR during S-phase, lack of BRCA1 impairs repair of these DSBs and leads to activation of cell
cycle arrest and/or cell death. Thus, treatment of BRCA1-mutated cells with PARPi is a way to
selectively induce death. Despite the promising results of phase 2 trials the first phase 3 clinical
trial with iniparib, the most advanced PARPi, was disappointing as it did not improve patient
survival [126]. Given that double deficiency of BRCA1 & 53BP1 in mouse cells promotes
resistance to PARPi, it is likely that loss of 53BP1 is one of the key mechanisms activated by
BRCA1-mutated tumors to develop resistance to PARPi. This is supported by the fact that there
is decreased 53BP1 expression in a subset of BRCA1-associated breast cancers and that loss of
53BP1 is associated with a decreased likelihood of survival in breast cancer patients [88, 89].
Thus, 53BP1 is a key player in DNA damage repair and genomic stability, directly through its role
in NHEJ and indirectly through its crosstalk with the HR pathway.
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(vii) Aging and tumorigenesis
The likelihood of being diagnosed with cancer increases exponentially with age, up until
age 75 (Figure 2) [5], making age one of the greatest “risk factors” for cancer. In recent years, a
number of studies addressed whether or not age actually contributes to tumorigenesis or is
merely associated with it. This question has posed difficult to answer, as cancer and aging are
characterized by many of the same features such as genomic instability, cellular senescence,
autophagy and alterations in telomere biology [127]. Intriguingly, a number of human diseases
present with mutations in factors that are involved in DNA replication and the DDR pathways
[128] (See table 2). A whole body of evidence indicates that mutations in factors involved in DNA
replication, the DDR pathway or mechanisms of DNA repair result in premature aging and
increased cancer susceptibility [128-130].

Mutations in the gene coding for Werner protein (WRN) give rise to Werner Syndrome, a
premature aging disease which associates with increased risk of cancer, especially carcinomas
and sarcomas [130]. WRN is a member of the RecQ family of DNA helicase and displays both
helicase and exonuclease activity, which are necessary for DNA replication. Patients afflicted with
Werner Syndrome present with premature aging which begins to manifest in early adulthood with
features such as grey hair, wrinkled skin, bone loss, diabetes type II and atherosclerosis. Cells
from these patients are characterized by increased chromosomal instability and prolonged Sphase [131, 132]. A report on cells from a Werner Syndrome patient indicated abnormalities in
nuclear shape, such as nuclear invaginations and protrusions, suggesting possible defects in
nuclear organization [133]. Interestingly, several heterozygous mutations in the LMNA gene,
which codes for the nuclear structural proteins lamin A and lamin C, also cause a similar
phenotype, Atypical Werner Syndrome, which features premature aging, bone loss and diabetes
[134-136]. However, there have been no reports on genomic instability in LMNA-associated
Atypical Werner Syndrome to date.
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Table 2. A number of diseases that manifest premature aging are associated with mutations in
genes involved in the DNA damage response pathways.
Premature Aging Syndromes Associated with
Mutations in DNA Repair Genes
Ataxia Telangiectasia (ATM)
Werner Syndrome (WRN)
Bloom Syndrome (BLM)
Dyskeratosis Congenita (DKC1, TERC)
Aplastic Anaemia (TERC, TERT)
Fanconi Anemia (Fanc genes)
Nijmegen Breakage Syndrome (NBM)

Another interesting link between A-type lamins and premature aging is manifested by the
most severe premature aging disease, Hutchinson-Gilford Progeria Syndrome (HGPS) [137-140].
HGPS arises due to a mutation in the LMNA gene which results in production of a mutant protein,
progerin. Children with HGPS appear normal at birth but within a year they begin to manifest
characteristic features of aging such as shortened stature, craniofacial disproportion, alopecia
(hair loss), osteoporosis and abnormal distribution of fat. These children die very young, usually
by their early teens, due to severe atherosclerosis and cardiovascular complications.
Interestingly, progerin has also been shown to accumulate in cells from aged individuals, further
implicating A-type lamins in aging and tumorigenesis. Along these lines, HGPS fibroblasts
undergo faster telomere attrition than their normal counterparts and have global defects in the
epigenetic

marks

characteristic

of constitutive

heterochromatin

[22, 141].

Given

the

commonalities between aging and cancer and the link between A-type lamins and premature
aging, we speculate that the molecular mechanisms responsible for the pathogenesis of LMNA
mutations might be similar to those involved in cancer and physiological aging.
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(viii) A‐type lamins: structure and distribution
A-type lamins are type V intermediate filaments found exclusively in the nuclei of
differentiated cells [12, 142, 143]. The major products of the LMNA gene are lamin A and its
smaller splice variant lamin C, which lacks 92 amino acids at the C-terminus. Minor products of
the LMNA gene are lamin A∆10 and lamin C2, a testis specific protein [144]. A-type lamins are
expressed only in differentiated cells and are absent during embryogenesis up until mouse
embryonic day 12, where tissue-specific expression becomes apparent [145]. While most adult
tissues express A-type lamins a few, including cells of the immune system such as B and T
lymphocytes, cells isolated from the bone marrow, and pancreatic islets, show little to no
expression [146].

Within the nucleus, A-type lamins form coiled-coil filaments that are juxtaposed to the
inner nuclear membrane as a filamentous mesh that interacts with locally distributed proteins
such as integral nuclear membrane proteins, B-type lamins and lamins-associated proteins (LAP)
[144]. A fraction of lamin A/C extends throughout the nucleoplasm where they also interact with
numerous proteins involved in cell cycle regulation, including Rb and PCNA [147-149]. Initial
translation of the LMNA transcripts yields mature lamin C and a premature form of lamin A,
prelamin A, which undergoes extensive post-translational processing to yield the mature form.
Prelamin A contains a C-terminus CAAX motif which is targeted for farnesylation for attachment
to the inner nuclear membrane. Following farnesylation, the Zmpste24 enzyme cleaves prelamin
A at a specific site within the C-terminus. This cleavage relieves lamin A of its farnesylation and
produces mature lamin A. A-type lamins are thought to play a scaffolding role for tethering
chromatin to specific sub-compartments, which in turn serves to organize nuclear processes [7, 9,
12, 150]. In fact, depletion of A-type lamins or expression of mutant forms of the proteins leads to
defects in chromatin remodeling and in the 3D organization of the genome, as exemplified by loss
of heterochromatin from the nuclear periphery [13, 151].
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(ix) A‐type lamins and disease
Alterations in the processing of lamins A/C, either through mutations in the LMNA gene or
the processing enzymes, can lead to pathogenesis. In particular, mutations in the LMNA gene are
associated with a number of degenerative diseases, collectively termed laminopathies, which are
divided into two broad non-exclusive categories: diseases that affect striated muscle (muscular
dystrophies) and diseases that affect adipose tissue (lipodystrophies) and bone [12, 142, 154].
The muscular dystrophies are characterized by wasting or lack of development of muscular tissue
and include autosomal dominant emery-dreyfuss muscular dystrophy (AD-EDMD), limb-girdle
muscular dystrophy 1B (LDMD1B) and dilated cardiomyopathy (DCM). Diseases of the adipose
tissue and bone feature hyperlipidemia, aberrant distribution of white adipose tissue, and
sometimes abnormal bone structure in diseases such as familial partial lipodystrophy (FPLD) and
mandibuloacral dysplasia (MAD). In an overlapping phenotype, mutations in A-type lamins can
feature defects in both adipose tissue and bone structure, as well as defects in striated muscle,
as seen in HGPS, a severe premature aging disease. HGPS is caused by a single mutation
(1824C>T, G608G) which results in activation of a cryptic splice site within the LMNA gene,
leading to removal of the Zmpste24 cleavage site [140, 155]. This aberrant version of lamin A
(known as progerin) is still farnesylated, however absence of the Zmpste24 cleavage site
prevents further processing and it accumulates at the nuclear membrane, causing abnormalities
in the nuclear shape such as nuclear blebbing and invagination [139].

(x) Mouse models of laminopathies
In an effort to understand the pathogenesis behind LMNA mutations, several groups have
developed mouse models of various laminopathies [156]. These mouse models of laminopathies
have ranged from deletion of the LMNA gene (Lmna-/-) or a lamin A-processing enzyme
(Zmpste24-/-) to introduction of various mutations in the LMNA gene [151, 157]. The different
mouse models reproduce varying spectrum of human laminopathies. The Lmna-/- and Zmpste24-/mice have been most extensively characterized. Zmpste24-/- mice are normal at birth up until 4
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weeks, after which they present decreased growth rate, size, abnormal posture, muscular
dystrophy and loss of subcutaneous fat [157, 158]. These mice eventually succumb to death
within 20 weeks due to dilated cardiomyopathy and heart failure. The Lmna-/- mice are very
similar to the Zmpste24-/-, showing growth retardation, lipodystrophy, muscular dystrophy, cardiac
and skeletal myopathy and death within 8 weeks [151]. Most of what we currently understand
about the role of A-type lamins in pathogenesis has been gleaned from studies in the mouse
models of laminopathies.

A-type lamins function in a number of nuclear processes, including positioning of nuclear
pore complexes, interaction with chromatin, DNA synthesis and transcription [10, 11, 159].
However, the exact molecular mechanisms behind the function of lamins in these processes
remain undefined. Studies from the Zmpste24-/- mice as well as cells from HGPS patients have
shed some light on the mechanisms which might contribute to pathogenesis. Bone marrow cells
from the Zmpste24-/- mice have increased genomic instability, characterized by chromosome
breaks and presence of γ-H2AX foci, while fibroblasts from HGPS patients and Zmpste24-/- mice
have alterations in the DDR [152, 160]. At a molecular level, HGPS and Zmpste24-/- MEFs
showed delayed recruitment of 53BP1 to DNA repair foci upon treatment with ionizing radiation,
and delayed disappearance of these foci [152]. Interestingly, Zmpste24-/- MEFs are thought to
have enhanced NHEJ, based on their increased ability to efficiently re-join a linearized plasmid
after transient transfection. Zmpste24-/- MEFs also showed impaired recruitment of RAD51 to
sites of DNA damage leading to a delayed checkpoint response and defective DNA repair,
suggestive of impaired HR [152]. In additional support of a role for A-type lamins in the DDR,
ectopic expression of mutant forms of lamin A in the presence of wild-type lamin A/C was
sufficient to inhibit formation of γ-H2AX-labeled DNA repair foci in response to mild doses of
cisplatin or UV irradiation [161]. All these reports suggest that unprocessed prelamin A and
truncated lamin A act in a dominant negative fashion to perturb DNA damage response and
repair.
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(xii) A‐type lamins and cancer
Aberrant nuclear morphology and changes in the nuclear lamina are emerging as
characteristic features of cancer cells [8]. This suggests that factors that are important
determinants of nuclear architecture might be relevant for understanding tumorigenesis. In fact,
the expression of A-type lamins has been shown to be altered in a number of malignancies
including small cell lung carcinoma (SCLC) and certain types of gastrointestinal neoplasms [14,
17, 162, 163]. Furthermore, A-type lamins are implicated in a variety of pathways that are
involved in genomic instability and tumorigenesis. One of the most notable pathways involves the
stabilization of the retinoblastoma tumor suppressor proteins pRb and p107 by A-type lamins.
Using cells from wild-type and Lmna-/- mice, Johnson et al. (2004) demonstrated interaction
between A-type lamins and pRb, and that loss of A-type lamins leads to increased proteasomal
degradation of pRb and p107 [148]. Given the significant roles of pRb and p107 as bona-fide
tumor suppressors [164], the mechanism by which they are regulated is of relevance to this field.
However, studies attempting to understand the mechanism of lamins-dependent pRb/p107
degradation have only managed to demonstrate that MDM2 and gankryin, the pathways currently
known to regulate their stability, are not involved in this process [165]. Thus loss of A-type lamins
leads to degradation of pRb/p107 by a mechanism that has remained elusive.

Given that A-type lamins are strongly implicated in aging and are emerging to be relevant
for cancer, we hypothesized that they are involved in the maintenance of genomic stability. To
test this hypothesis we investigated various components of genomic instability, such as
alterations in telomere biology, chromosomal structure and the efficacy of DNA damage repair
pathways in lamin A/C-proficient or deficient mouse and human cells. Strikingly, we found that
lamin A/C-deficiency was associated with gross abnormalities in telomere structure and nuclear
organization, as well as significant inhibition of the two major pathways of DNA DSBs repair. Our
studies reveal a novel relationship between A-type lamins and both NHEJ and HR: A-type lamins
promote NHEJ through stabilization of 53BP1, whereas they promote HR by transcription of
BRCA1 and RAD51 genes. Furthermore, these studies have led to the discovery of new
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pathways that are involved in the regulation of 53BP1 and the retinoblastoma pocket family
proteins, and that are activated in disease states independently of A-type lamins.
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CHAPTER ONE

Loss of A‐Type Lamins Affects Telomere Homeostasis and Genomic
Stability in Mammalian Cells
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ABSTRACT
Research performed in the last few years has revealed important roles for the spatial and
temporal organization of the genome on genome function and integrity. A challenge in the field is
to determine the molecular mechanisms involved in the organization of genome function. A-type
lamins, key structural components of the nucleus, have been implicated in the maintenance of
nuclear architecture and chromatin structure and have a prevalent connection to disease.
Mutations in the LMNA gene are linked to a wide variety of degenerative disorders termed
laminopathies, whereas changes in the expression of lamins are associated with tumorigenesis.
However the molecular pathways affected by alterations of A-type lamins and how they contribute
to disease are poorly understood. To gain insight into the mechanisms that contribute to
pathogenesis, we determined whether loss of A-type lamins affects overall genomic stability and
telomere homeostasis in LMNA knockout mouse fibroblasts. Intriguingly, we find that loss of Atype lamins alters the nuclear distribution of telomeres and is also associated with telomere
attrition, defective assembly of telomeric heterochromatin, and increased chromosomal instability.
This study reveals new functions for A-type lamins in the maintenance of genomic integrity and
suggests that alterations of telomere biology may contribute to the pathogenesis of lamin-related
diseases.

1.1 Altered nuclear organization of telomeres
Three dimensional (3D) analysis of telomere positioning indicates that mammalian
telomeres are distributed throughout the entire nuclear volume in G0/G1/S phases of the cell
cycle, whereas they assemble into a telomeric disk at the center of the nucleus during G2 in
preparation for mitosis [166]. The molecular mechanisms that ensure proper nuclear localization
of mammalian telomeres and their relevance in telomere metabolism remain undefined.
Interestingly, the 3D positioning of telomeres is altered in tumor cells [167] and in senescent cells
presenting defects in the nuclear lamina [168], suggesting a relationship between nuclear
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distribution of telomeres and alterations of telomere metabolism observed during senescence and
immortality.

To determine whether A-type lamins have a role in the nuclear compartmentalization of
telomeres, we compared the distribution of telomeres between wild-type (Lmna+/+) mouse
embryonic fibroblasts (MEFs) and MEFs devoid of A-type lamins (Lmna-/-). MEFs were analyzed
after spontaneous immortalization in culture. Cells were subjected to 3D telomere fluorescence in
situ hybridization (3D-FISH), imaged and analyzed for telomere distribution (Figure 6A). The
distances of each telomere to the nuclear edge was determined using the TeloView program
[169]. We found a clear difference in telomere distribution between the two genotypes (Figure
6B), such that lamins-deficient cells had a shift in the localization of telomeres towards the
nuclear periphery. By calculating the cumulative distribution of telomere intensities we show that
approximately 20% of telomere signals were found at the very edge of the nucleus (≤0.4 μm) in
both genotypes (Figure 6C). However, although the remaining 80% of telomeres in Lmna-/- cells
accumulated within a distance of 1.75 μm from the edge, telomeres in Lmna+/+ MEFs were more
dispersed throughout the nucleoplasm.

These results clearly show that A-type lamins participate in the correct distribution of
telomeres throughout the entire nuclear volume, with a significant shift in distribution towards the
nuclear periphery and away from the nuclear centre upon loss of A-type lamins. Fluorescenceactivated cell sorting analysis carried out on proliferating Lmna-/- and Lmna+/+ immortalized
fibroblasts indicated that changes in telomere distribution were not due to differences in cell-cycle
profiles between genotypes [170]. In addition, chromatin immunoprecipitation (ChIP) assays
performed using lamin A/C antibody showed binding of lamins to telomeres [170], suggesting that
tethering of telomeres to the lamins scaffold might regulate their nuclear distribution.

30

CHAPT
TER 1

Fiigure 6. Altered distributtion of telom
meres in Lmn
na‐/‐ cells. (A)) Representattive reconstrructed
+/+
‐/‐
im
mages of nucclei from Lm
mna and Lm
mna MEFs processed b
by 3D FISH w
with a fluoreescent
te
elomere prob
be (shown in
n red). DAPII counterstai ned DNA is shown in b
blue. 3D telo
omere
distribution th
hroughout th
he nuclear sp
pace is show n. (B) Distrib
bution plot o
of the intenssity of
te
elomere signaals with respe
ect to distancce of signals ffrom the edgee of nuclei. In
ntegrated inteensity
re
epresents sum intensity of all telomeres at a di stance from edge ≤ to X. (C) Cumu
ulative
distribution fu
unction (CDF)) showing inttegrated inteensity in relaation to distaance from nu
uclear
ed
dge. Integrate
ed intensity is defined as: (sum intensitty of telomerres at a distan
nce from edge ≤ to
X)/(sum intensity of all te
elomeres). No
o changes inn the pool of telomeres between thee two
ge
enotypes werre observed at
a the very ed
dge of nuclei. In contrast, higher pools of telomeress were
fo
ound at all pe
eripheral disttances in Lmn
na‐/‐ MEFs, w
when compareed with Lmnaa+/+ MEFs. 3D
D FISH
was
w carried ou
ut three time
es. Telomeress in 85 nucleei of Lmna‐/‐ M
MEFs and 81
1 nuclei of Lm
mna+/+
MEFs
M
were anaalyzed.

31
1

CHAPTER 1

1.2 Telomere attrition in lamins‐deficient cells
To determine whether changes in telomere distribution upon loss of A-type lamins are
accompanied by alterations of telomere metabolism, we compared telomere length between
multiple sets of Lmna+/+ and Lmna-/- MEFs of early passage (pre-senescent). Analysis by terminal
restriction fragment (TRF) [171] showed faster migration of telomeres in all five Lmna-/- lines
compared to Lmna+/+ lines, indicating a moderate but highly consistent telomere shortening upon
loss of A-type lamins (Figure 7A). These results were confirmed by quantitative fluorescence In
situ hybridization (Q-FISH) [171] of metaphase nuclei using a telomeric probe. While mean
telomere lengths of Lmna+/+ lines ranged between 37.6 and 40.8 kb, with an average telomere
length of 39.0 kb, all five lines of Lmna-/- MEFs presented lower mean telomere length than any of
the Lmna+/+ lines, ranging between 34.0 and 35.2 kb, with an average telomere length of 34.6 kb
(Figure 7B). To determine whether these differences were statistically significant, we carried out a
two-sided t-test considering the mean from each of the cell lines to be an independent sample of
either Lmna+/+ or Lmna-/- genotype. We found that the mean telomere length is significantly
different between these two genotypes (P=0.0003). In addition, TRF analysis of adult fibroblasts
from Lmna-/- mice also showed a more pronounced telomere shortening phenotype [170].

To test whether acute depletion of A-type lamins would also lead to telomere attrition, we
lentivirally transduced wild-type MEFs with constructs carrying shRNA specific for depletion of Atype lamins (shLmna) or shRNA specific for luciferase (shLucif) as control. Transduction using
shLmna led to undetectable levels of lamin A/C (Figure 7C). Telomere length analysis by Q-FISH
revealed a marked decrease in telomere length after only five passages of the cells in culture
(Figure 7D). Most importantly, reintroduction of either lamin A, lamin C, or both, by retroviral
transduction of A-type lamins-depleted cells rescued the telomere shortening phenotype to
varying degrees (Figure 7D). Overall, reintroduction of lamins led to a significant increase in
average telomere length, as well as a decrease in the pool of short telomeres and an increase in
the pool of long telomeres.

32

CHAPT
TER 1

Fiigure 7. Deffective main
ntenance of telomere llength upon
n loss of A‐‐type laminss. (A)
Representative
e TRF analysiss of several in
ndependent LLmna+/+ (1–4)) and Lmna‐/‐ (A–E) MEF lin
nes of
‐/‐
–5). Note the
e faster migraation of telom
meres in all LLmna lines when
eaarly passage (passages 3–
co
ompared with Lmna+/+ lines, indicatingg telomere shhortening. (B
B) Telomere llength distrib
bution
(e
expressed as average ± s.d
d.) in Lmna+/++ (1–4) and Lm
mna‐/‐ (A–E) M
MEFs as deteermined by Q
Q‐FISH.
Th
he individual values for eaach of the sam
mples are shoown. Q‐FISH w
was carried out three timees. For
eaach experime
ent, at least 20
2 metaphase
es were anal yzed in everyy MEF line. (C
C) Western b
blot to
detect the levvels of lamin
n A/C on len
ntiviral transdduction of w
wild‐type MEFFs with constructs
caarrying shRNA
A specific forr lamin A/C (sshLmna) or ann shLucif con
ntrol, as well as cells expreessing
laamin A, lamin C, or both
h. (D) Q‐FISH
H analysis too measure teelomere lenggth in MEFs after
depletion of A‐type lamins (compare shLLmna and shLLucif) and resscue with expression of lam
min A,
laamin C or both lamin A and
d C. *Represe
ents P‐value oof statistical ssignificance.

33
3

CHAPTER 1
These data indicate that A-type lamins play a key role in the control of telomere length.
However, we do not know the mechanism behind the telomere shortening phenotype observed in
A-type lamins-deficient cells. The levels of telomerase activity and the binding of the shelterin
complex components TRF1 and TRF2 were not affected by the loss of A-type lamins [170].
Similarly, we did not observe any evidence of aberrant recombination at telomeres, which could
explain the loss of telomeric sequences [170]. It is possible that the binding of other shelterin
complex components or DNA repair factors with a function at the telomere could be defective in
LMNA null cells. Alternatively or concomitantly, loss of A-type lamins might hamper the
accessibility of telomerase or other proteins implicated in telomere metabolism, especially factors
implicated in telomere replication. While the mechanisms remain unclear, our data clearly show
that A-type lamins have a key role in the maintenance of telomere length homoeostasis.

1.3 Abnormal heterochromatin assembly
Maintenance of the heterochromatic structure of telomeres is important for telomere
length homoeostasis [56, 172]. A common feature in fibroblasts from HGPS patients and from old
individuals expressing progerin is the global alteration of histone marks characteristic of
constitutive heterochromatin [173, 174], however the effect on telomeres is unknown. To
investigate whether loss of A-type lamins affects the assembly of telomeric heterochromatin, we
carried out ChIP assays using antibodies recognizing well-established heterochromatic marks,
H3K9me3 and H4K20me3. Although we found no changes in H3K9me3 levels, we observed a
significant decrease in telomeric H4K20me3 levels in Lmna-/- MEFs (Figure 8A). Interestingly,
these defects were phenocopied by pericentric heterochromatin (Figure 8B), supporting the idea
that alterations of A-type lamins function affect the epigenetic status of constitutive
heterochromatin [174]. Notably, the changes reported here are different from those described in
HGPS cells, indicating different functional implications of mutation or silencing of the LMNA gene.
The epigenetic defects of Lmna-/- MEFs were confirmed by western blot analysis, which showed a
marked reduction in global H4K20me3 levels but no changes in H3K9me3 (Figure 8C).
Additionally we found significant decreases in the expression of non-coding telomeric RNAs
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1.4 Increased genomic instability
Next, we evaluated the presence of genomic instability in Lmna-/- cells. We determined
the frequency of loss of telomeric signals (signal-free ends), chromosome/ chromatid breaks and
end-to-end fusions, as well as the presence of aneuploidy in pre-senescent Lmna+/+ and Lmna-/MEFs (Figure 9). We found a threefold increase in the number of signal-free ends (Figure 9A)
and a twofold increase in chromosome and chromatid breaks (Figure 9B) in Lmna-/- MEFs,
indicating increased genomic instability. This finding was supported by an increased number of
nuclei with basal DNA damage, as indicated by a twofold increase in cells presenting γ-H2AXlabeled foci upon loss of A-type lamins (Figure 9C).

In normal cells, inappropriate recombination between telomeres of sister chromatids can
serve to lengthen one telomere at the expense of another [175]. To test whether aberrant
recombination involving telomeric repeats contributed to the loss of telomere signals in Lmna-/MEFs, we carried out chromosome orientation fluorescence in situ hybridization (CO-FISH) [175].
This technique allows the differential labeling of leading and lagging strands of telomeres. In the
absence of recombination events between telomeric sequences, only one telomere at each
chromosome end is labeled with either the leading or the lagging strand probe. If recombination
occurs, the labeling is split between both sister telomeres, giving rise to telomeres labeled with
both the leading and lagging strand probes. CO-FISH results indicated that loss of A-type lamins
did not lead to increased telomeric recombination events [170]. Thus, alternative mechanisms are
responsible for the loss of telomere signals upon loss of A-type lamins.

In addition to telomeric instability, karyotype analysis showed an increase in the numbers
of cells with abnormal chromosome dosage in Lmna-/- MEFs (Figure 9D). Since earlier studies
had shown that reduced Rb family function leads to aneuploidy partly due to defects in
centrosome duplication [176], we tested if loss of A-type lamins was leading to errors in
centrosome duplication. This was done by quantifying the centrosome numbers in Lmna+/+ and
Lmna-/- MEFs by performing immunofluorescence staining of γ-tubulin. Lmna-/- cells had an
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1.5 DISCUSSION
Understanding the cellular functions of A-type lamins is a highly topical subject because
of their implication in a number of disease states, including laminopathies, aging and cancer. In
particular, reduced expression of A-type lamins is emerging as a factor contributing to
tumorigenesis [14, 15, 162]. Our results indicate that A-type lamins play a fundamental role in the
maintenance of telomeres and genomic stability. We have shown that loss of A-type lamins leads
to a variety of alterations in telomere biology: (i) nuclear decompartmentalization of telomeres, (ii)
impaired maintenance of telomere length homoeostasis, and (iii) defects in telomere chromatin
architecture. In addition, we found that loss of A-type lamins resulted in an increase in basal
levels of DNA damage (γ-H2AX foci), increased frequency of chromosome and chromatid breaks,
and aneuploidy. Given that alterations of telomere biology is one of the hallmarks of cancer and
aging, we suspect that the observed alterations upon loss of A-type lamins are contributing to the
pathogenesis of lamin-related diseases, especially premature aging syndromes such as HGPS
and tumoral processes characterized by the silencing of the LMNA gene.

Various lines of evidence indicate that the nucleus is compartmentalized and that
changes in the spatial organization of chromatin affect nuclear functions [6, 10, 11]. The
importance of telomere compartmentalization for telomere function has been clearly shown in
yeast [177]. To date, the mechanisms regulating the nuclear distribution of mammalian telomeres
remain to be identified. In addition, how the nuclear localization of mammalian telomeres
influences telomere biology is unknown. Lamins, which are absent in yeast, can bind directly to
DNA and core histones, which attributes them a major role in tethering chromatin to specific subnuclear compartments [178, 179]. Our results show that A-type lamins associate with telomeres
and contribute towards their proper nuclear localization.

In normal cells, A-type lamins are highly enriched at the nuclear periphery and are also
found throughout the nucleoplasm [180]. We thus reasoned that loss of A-type lamins could lead
to the detachment of telomeres from the nuclear periphery. In contrast, we found that the
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localization of telomeres shifted towards the nuclear periphery in the absence of A-type lamins.
This raises the possibility that the nuclear periphery represents a default pathway for telomere
localization. In this model, A-type lamins would have an active role in the localization of telomeres
throughout the nucleoplasm in mammalian cells. A recent study showing that alterations of the
nuclear lamina during senescence are associated with increased aggregation of telomeres at the
nuclear periphery supports this model [168]. It remains to be investigated whether tumor cells
with silenced LMNA gene also present alterations in telomere compartmentalization and telomere
structure, length, and function. These types of studies will provide insights into the mechanisms
altered upon loss of A-type lamins, which could contribute to tumorigenesis.

The profound impact that loss of A-type lamins has on different aspects of telomere
biology suggests that the nuclear compartmentalization of telomeres could be fundamental for
telomere metabolism. Our results do not indicate that changes in telomerase activity, binding of
the shelterin complex components TRF1/ TRF2, or aberrant recombination are the cause of the
telomere shortening in Lmna-/- cells. It is possible that the accessibility of telomerase and/or
activities participating in telomere metabolism is reduced on disruption of the scaffold for nuclear
organization provided by A-type lamins. Studies aimed at elucidating the impact of loss of A-type
lamins on telomere replication, and on the binding of other shelterin complex components or DNA
repair factors to telomeres will be fundamental to understanding the mechanisms behind the
alterations in telomere biology described here.

In addition to the effect on telomere biology, loss of A-type lamins impacts on other
molecular mechanisms, such as stabilization of Rb and ING tumor suppressors [148, 181, 182].
Alterations in these tumor suppressors could contribute to the telomere phenotypes in Lmna-/MEFs and to the genomic instability that drives cancer and aging. While reduced Rb family
function is likely to be responsible for histone modifications defects in Lmna-/- cells, we showed
that the telomere-shortening phenotype and the decrease in density of TERRAs are Rb
independent [183].
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Along with changes in telomere metabolism, Lmna-/- cells were also characterized by
increased chromosomal instability as manifested by chromosome and chromatid and chromatid
breaks, and loss of telomeric signal from chromosomes. These cells also had a higher basal level
of DNA damage, which we detected as γ-H2AX foci. The increase in signal-free ends was
particularly interesting because they suggested the presence of deprotected telomeres in the
Lmna-/- cells. Deprotected telomeres are potent inducers of the DNA damage response and
undergo processing as DSBs by the non-homologous end-joining (NHEJ) pathway. Processing of
telomeres by NHEJ results in fusions between telomeres of different chromosomes however
there was no increase in the frequency of end-to-end fusions in the Lmna-/- cells, indicating
defective NHEJ in these cells. In the next section we investigate the efficacy of NHEJ in laminsdeficient cells, and the molecular mechanisms by which loss of A-type lamins could contribute to
the genomic instability.
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ABSTRACT
A-type lamins are emerging as regulators of nuclear organization and function. Changes
in their expression are associated with cancer and mutations are linked to degenerative diseases
-laminopathies-. Although a correlation exists between alterations in lamins and genomic
instability, the molecular mechanisms remain largely unknown. In the previous chapter we
showed that loss of A-type lamins leads to alterations in the homeostasis and nuclear distribution
of telomeres in mouse cells. Cells lacking A-type lamins had increased genomic instability with
increased basal DNA damage signaling, chromosome and chromatid breaks, and loss of
telomeric signal (signal-free ends). Despite the presence of signal-free ends, lamins-deficient
cells did not exhibit any changes in the frequency of chromosome end-to-end fusions, suggesting
an inhibition of the non-homologous end-joining (NHEJ) pathway. Here, we determined if A-type
lamins are required for efficient NHEJ of DNA double-strand breaks (DSBs) using deprotected
telomeres as a model of long-range DSBs, and ionizing radiation-induced breaks as a model of
short range DSBs. Strikingly, we find that loss of A-type lamins significantly inhibits NHEJ of both
types of DSBs. We demonstrate that the mechanism behind deficient NHEJ is degradation of
53BP1, an important NHEJ protein. Importantly, reconstitution of 53BP1 in lamins-deficient cells
is sufficient to rescue both long-range and short-range NHEJ. These findings are significant as
they uncover previously unknown mechanisms by which A-type lamins contribute to genomic
stability and offer new avenues for development of therapy for laminopathies and cancer.

2.1 Suppression of long‐range NHEJ in lamin A/C‐deficient cells
First, we artificially induced telomere deprotection by expression of a dominant negative
telomere binding protein, TRF2∆B∆M, by retroviral transduction of Lmna+/+ and Lmna-/- MEFs.
Expression of TRF2∆B∆M has been established to induce telomere dysfunction, which leads to
chromosome end-to-end fusions in the presence of an intact NHEJ repair pathway [50, 184]
(Figure 10). NHEJ processing of deprotected telomeres leads to the recruitment of DNA repair
proteins to the telomeres, which can be visualized as “telomere induced foci” (TIF) when
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2.2 A‐type lamins stabilize 53BP1
To gain insight into specific steps of NHEJ that are affected by loss of A-type lamins, we
tested whether the cellular levels of key components of the DDR pathway were altered in Lmna-/MEFs. First, we monitored the levels γ-H2AX and 53BP1, which have a function in the sensing of
dysfunctional telomeres. While there was no difference in the level of H2AX in lamins-deficient
cells, we confirmed our previous observation of increased γ-H2AX in Lmna-/- MEFs, indicating
increased basal DNA damage upon loss of A-type lamins (Figure 13A). In addition, we observed
a marked decrease in the levels of 53BP1 in Lmna-/- MEFs when compared with Lmna+/+ cells by
both western blot and immunofluorescence (Figure 13A). Consistent with the Lmna-/- MEFs, acute
depletion of A-type lamins in U2OS cells by shRNAs also led to a significant decrease in 53BP1
protein (Figure 13B). Importantly, reconstitution of either lamin A, lamin C, or both lamin A and
lamin C into lamins depleted cells rescued the levels of 53BP1 (Figure 13C).

To determine if other DDR proteins were affected by loss of A-type lamins, we monitored
the levels of a variety of proteins with different roles in the DDR pathway and in DNA repair in
lamins-deficient cells. Unlike 53BP1, we detected no significant differences in the cellular levels of
MDC1, ATM, DNA-PK, Mre11, Nbs1, Ku70, and ERCC1 (Figure 13D). In addition, we found no
differences in the global levels of TRF1, TRF2, and POT1— proteins with a key structural function
in telomeres (data not shown), which suggested that the defect in telomeric NHEJ is not likely to
be due to differences in the shelterin complex at the telomeres. These results indicate that
depletion of A-type lamins preferentially affects 53BP1 levels.

To investigate if the regulation of 53BP1 was occurring at the transcriptional level we
monitored the levels of 53BP1 transcripts by real-time quantitative PCR (Q-PCR). As shown in
Figure 14A, no differences in the levels of 53BP1 transcripts were detected between the two
genotypes, which suggested that A-type lamins were involved in regulating 53BP1 protein
stability. Interestingly, incubation of Lmna+/+ and Lmna-/- MEFs with the proteasome inhibitor
MG132 partially rescued the levels of 53BP1, implicating the proteasome pathway in degradation
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2.3 53BP1 rescues long‐range NHEJ in lamins‐deficient cells
To determine the contribution of 53BP1-deficiency to the NHEJ defect in lamins deficient
cells we performed 53BP1 rescue experiments in human cells. U2OS cells were retrovirally
transduced with 53BP1 or an empty vector (EV) control followed by lentiviral transduction with a
shRNA specific for depletion of A-type lamins (shLmna) or a shRNA control (shCtrl) (Figure 15A).
Next, we retrovirally transduced cells with a dominant negative of the telomere binding protein
TRF2 (TRF2∆B∆M) to induce telomere deprotection. To quantify the resulting end-to-end fusions,
we scored metaphases based on four different categories of increasing chromosome fusions
ranging from “less than 5 chromosomes fused” (category 1) to “more than half of the
chromosomes fused” (category 4) (Figure 15B and C). In cells that express A-type lamins and
have normal levels of endogenous 53BP1 (EV/shCtrl/TRF2∆B∆M), 53% of metaphases were
scored in category 1 and 31% in category 4 (Figure 15D). In contrast, lamin A/C-depleted cells
(EV/shLmna/TRF2∆B∆M) exhibited an overall decrease in the extent of end-to-end fusions (66%
category 1 and only 14% category 4). Most importantly, reconstitution of 53BP1 into lamin A/Cdepleted cells (53BP1/shLmna/TRF2∆B∆M) resulted in a rescue of chromosome fusions (36%
category 1 and 40% category 4). As a control, we monitored fusions in cells transduced with an
empty vector instead of TRF2∆B∆M (53BP1/shLmna/EV). As expected, 100% of metaphases
belong to category 1, indicating that 53BP1 expression itself does not induce fusions (data not
shown). We conclude that the effect of A-type lamins in NHEJ of dysfunctional telomeres is due
to their ability to stabilize 53BP1 protein.

Cathepsin L (CTSL), a cysteine protease which is upregulated upon loss of A-type
lamins, was demonstrated by our group to participate in degradation of 53BP1 in lamins-deficient
cells [187]. CTSL is a cysteine protease from the papain family that is ubiquitously expressed in
mouse and human tissues. Like other proteases, it is synthesized as a zymogen which
undergoes autoproteolytic processing within the lysosomal/endosomal compartment to release
the mature active form [188]. Though its activity is enhanced by low pH in the lysosome, CTSL
can also be found in other cellular organelles, where it can selectively process other targets at
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less acidic or even neutral environments [189]. CTSL can be secreted to the extracellular matrix
where it is known to degrade some of its components under physiological conditions –i.e. favoring
bone resorption in osteoclasts [189]. Increased extracellular CTSL has been reported in
numerous types of cancer and is often associated with increased invasiveness and metastasis
[190-192]. More recently, CTSL was found inside the nucleus, where in a more regulated fashion
it processes specific nuclear components such as histone H3 tails during stem cell differentiation
and the transcription factor CDP/Cux during cell cycle progression [193, 194].

Previous studies demonstrated that 1,25(OH)2D3 (vitamin D) inhibits CTSL activity in
colon cancer cells [195, 196]. Interestingly, treatment of lamin A/C-deficient cells with vitamin D is
sufficient to inhibit activity of CTSL activity and results in increased levels of endogenous 53BP1
[187]. To determine if restoration of endogenous 53BP1 was sufficient to rescue TRF2∆B∆M
induced telomere fusions we treated lamins-deficient cells with vitamin D and scored telomere
fusions (Figure 16). Wild-type MEFs with either a control shRNA (shGFP) or shRNA targeting Atype lamins (shLmna) were retrovirally transduced with TRF2∆B∆M or an empty vector control.
Cells were treated vitamin D or with a vehicle control (bovine growth serum, BGS) for 24hours
prior to collecting metaphases for analysis of telomere fusions by FISH. As expected, treatment of
shGFP cells with vitamin D had no effect on 53BP1 levels while similar treatment of shLmna cells
led to a significant increase in levels of 53BP1 (Figure 16A). Consistent with our previous
findings, the frequency of TRF2∆B∆M -induced fusions in shGFP cells treated with BGS was ~40%
while the shLmna cells of the same treatment had fusions in less than 10% of the metaphases
(Figure 16B and C). Remarkably, treatment of shLmna/TRF2∆B∆M cells with vitamin D was
sufficient to increase the frequency of fusions to ~30%. Along with our overexpression data, these
results provide conclusive evidence that A-type lamins mediate NHEJ processing of deprotected
telomeres via their ability to stabilize 53BP1
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Figure 16. Defects in NHEJ of
dysfunctional telomeeres are resscued
by recovvery of endoggenous 53BP1. (A)
Western blots of 53BP1 and laamins
upon exxpression of TRF2ΔBΔM in cells
proficient or deficient in A‐type laamins
(lentivirally transduceed with shCo
ontrol
or shLmn
na, respectivvely). The two cell
lines were treated w
with vitamin D or
vehicle co
ontrol (BGS) ffor 24 h. Actin was
used ass a loadin
ng control. (B)
phase
Represen
ntative images of metap
spreads from the d
different sam
mples
analyzed. Telomeres are labeled w
with a
specific
PNA
p
probe
(yeellow).
Chromosomess are stained with DAPI (b
blue). Red ar rows indicatee fusions. (C)) Quantificatiion of
th
he percentage of metaphaases presenting chromosoome end‐to‐eend fusions in
n cells treated
d with
ΔBΔM
eiither vitamin
n D or BGS after retroviral transducction with TRF2
. vitaamin D treattment
re
estores 53BP1
1 levels and normal
n
processsing of dysfuunctional telo
omeres in lam
mins‐deficientt cells,
le
eading to incrreased numb
ber of fusionss. WT MEFs retrovirally transduced w
with TRF2ΔBΔM were
ussed as a posittive control. A minimum of 20 metaphaases were anaalyzed per sample.
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2.4 Response of lamins‐deficient cells to IR‐induced DNA DSBs
By investigating the role of A-type lamins in NHEJ of deprotected telomeres, we revealed
a novel pathway that might be affected by laminopathic mutations and/or alterations in the
expression of A-type lamins. However, despite their tremendous usefulness as models of longrange DSBs, deprotected telomeres are significantly different from the intrachromosomal breaks
that might arise due to genotoxic insult to the cell. Telomeric DNA consists of TG-rich repeats, is
highly heterochromatinized, bound by a distinct group of sequence/structure specific proteins
(shelterin complex), and adopts a very specific tertiary structure. In fact, specific components of
the shelterin complex strongly affect recognition of telomeres by the DSB repair pathway and the
specific mechanism used to process them. Although many of the processes that contribute to
repair of normal intrachromosomal DSBs are also necessary for processing of deprotected
telomeres, repair of deprotected telomeres involves additional steps, such as maneuvering of the
shelterin complex to provide access to DDR proteins. As such, our findings on A-type lamins and
telomeric NHEJ could not automatically be extrapolated to repair of other forms of DSBs. To
develop a more inclusive understanding of DSB repair in lamins-deficient cells we investigated
the global repair of DSBs, which we induced by treating asynchronous cells with ionizing
radiation.

One of the earliest responses to DNA DSBs is phosphorylation of H2AX (γ-H2AX) in the
surrounding chromatin [197, 198] followed by recruitment of 53BP1 to the demarcated site [199].
These changes occur within minutes of exposure to IR and can be visualized as foci by
immunofluorescence. IR-induced foci (IRIF) are highly organized structures and are strictly
regulated during the course of the DNA damage response [200]. Changes in the kinetics of
formation and resolution of DNA repair foci are used as an indication of alterations in the DDR
pathway [69]. Here, we tested whether loss of A-type lamins alters the cellular response to IR by
evaluating the formation/resolution of γ-H2AX and 53BP1 IRIF. Lmna+/+ and Lmna-/- MEFs were
treated with 0.5 Gy of IR and immunofluorescence assays performed to label γ-H2AX and 53BP1
IRIF at different times post-IR. Cells presenting more than 5 foci were scored as positive for
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Fiigure 17. Spa
atio‐temporaal formation and resolutio
on of DNA rrepair foci induced by ion
nizing
+/+
‐/‐
ra
adiation. Lmn
na and Lmna MEFs were irradiatedd with 0.5 Gy or left untreated. Cells were
fixxed at differe
ent times posst‐IR (from 10
0 min to 24 h ) and subjectted to immun
nofluorescencce (IF)
with
w an antibo
ody recogniziing (A) γH2AX
X or (B) 53BPP1. Cells pressenting moree than 5 foci were
sccored as positive for respo
onding to IR. A total of 2000–300 cells w
were scored p
per time poin
nt and
per experimen
nt. The averagge ± standard
d deviation off three indepeendent experriments is sho
own.

re
esponding to IR. In agreem
ment with our previous stu
udies, untrea
ated Lmna-/- M
MEFs had a h
higher
pe
ercent of cellls that score
ed positive fo
or γ-H2AX fo
oci (Figure 17A). Howeve
er both geno
otypes
se
ensed IR-indu
uced damage
e similarly, so that nearly 100% of MEFss had formed γ-H2AX foci by 10
min
m post-IR. Resolution
R
of γ-H2AX
γ
foci (starting
(
at 4h
hrs post IR) w
was also grosssly similar in
n both
ge
enotypes. Ho
owever at 24
4h post-IR th
he Lmna+/+ ccells had revverted to bassal levels of DNA
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damage while the Lmna-/- cells still exhibited residual γ-H2AX IRIF, which indicated an incomplete
response to the DNA damage. Given the decreased 53BP1 in lamin A/C-deficient cells, we
determined if the kinetics of 53BP1 IRIF was altered in the Lmna-/- and Lmna+/+ cells. As with γH2AX IRIF, nearly 100% of the cells in both genotypes responded to IR by forming 53BP1labeled foci, and the overall kinetics of formation and resolution of 53BP1 DNA repair foci was
similar in both genotypes (Figure 17B).

While the ability of cells to form 53BP1 IRIF was unaffected by the absence of A-type
lamins, we observed a profound and consistent decrease in the intensity of fluorescence of
53BP1 IRIF in Lmna-/- MEFs with respect to Lmna+/+ controls at all times post-IR (Figure 18 and
data not shown). Striking differences in intensity were observed at 30 min, 1 h, and 2h after IR.
By 24 h, 53BP1 protein was dispersed throughout the nucleus in Lmna+/+ cells, mirroring the
localization of the protein in cells that were not irradiated. In contrast, Lmna-/- fibroblasts still
displayed decreased 53BP1 intensity, and there were changes in its nuclear distribution so that
rather than having a disperse distribution, it had accumulated in a few large foci. Since the
intensity of labeling with γ-H2AX foci was indistinguishable between Lmna+/+ and Lmna-/- cells
throughout the time course of the experiments, we conclude that the difference in 53BP1
accumulation in Lmna-/- cells is specific to that protein and not due to widespread changes in the
DDR proteins.

Large 53BP1 nuclear bodies, similar to what we observed, were recently shown to
colocalize with OPT (Oct-1, PTF, transcription) domains in G1 BJ fibroblasts [201]. These 53BP1OPT domains were characterized by low levels of transcriptional activity and co-localized with γH2AX and MDC1. The authors proposed that the 53BP1-OPT bodies mark damaged DNA,
particularly fragile chromosome sites, where replication is incomplete. In support of this model,
treatment of cells with low levels of aphidicolin, which induces DNA damage at fragile sites [202],
but not hydroxyurea increased the formation of 53BP1-OPT bodies. Future studies will determine
if the large 53BP1 foci we observe upon treatment of Lmna-/- with IR colocalize with OPT
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gile sites in Lmna-/- cellss have incre
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Lmna-/- cells d
do not
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Fiigure 18. Deccreased accum
mulation of 53BP1
5
at IRIFF in Lmna‐/‐ M
MEFs. Lmna+/++ and Lmna‐/‐ MEFs
were
w
irradiated with 0.5 Gyy or left untre
eated. Cells w
were fixed at d
different timees post‐IR (fro
om 30
min
m to 24 h) and subjecte
ed to immuno
ofluorescencee (IF) with an antibody rrecognizing 53BP1.
Pictures of fie
elds selected
d randomly were taken under the ssame conditions of expo
osure.
Representative
e images of fo
our cells per condition
c
aree shown in each panel.
Given the differenc
ces in accum
mulation of 53
3BP1 at the IRIF and the
e role of 53B
BP1 in
NHEJ,
N
we spe
eculated thatt decreased accumulation
n of 53BP1 a
at the break sites might affect
do
ownstream effectors
e
of th
he DDR pathway. In a p
previous mod
del, Fernandez-Capetillo et al.
su
uggested thatt phosphoryla
ation of H2AX
X induces an increase in th
he local conce
entration of 5
53BP1
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ged DNA/chro
omatin, which
h serves as a platform forr interaction w
with differentt DDR
arround damag
fa
actors [109]. Defects in γ--H2AX and 53BP1
5
were predicted to result in imp
paired activation of
do
ownstream effectors
e
of th
he signaling and repair o
of DNA dama
age. Based o
on this mode
el, we
de
ecided to inv
vestigate if de
ecreased acc
cumulation off 53BP1 in Lm
mna-/- cells a
affects downstream
siignaling in the
t
DDR pa
athway. A ce
entral event in IR-inducced DDR is ATM -depe
endent
ph
hosphorylatio
on of p53 at Ser15. Phos
sphorylation o
of p53 activa
ates checkpo
oints that slow
w cell
cy
ycle progress
sion until the damage is re
epaired. Desp
pite significan
nt decreases in 53BP1 att IRIF,
Lm
mna-/- fibroblasts could ro
obustly phosphorylate p5
53 at Ser15 in response to IR (Figurre 19)
in
ndicating that the loss of A-type
A
lamins
s did not hin
nder the activvation of this downstream DDR
efffector. Furth
hermore, therre was norm
mal induction of p21 in la
amins-deficie
ent cells (datta not
sh
hown). These
e results indic
cate that the loss of A-type
e lamins doess not hinder th
he activation of the
DDR
D
pathway.

Fiigure 19. Pho
osphorylation of p53 in Lmna+/+ and Lmna‐/‐ MEFFs treated w
with IR. Cells were
trreated with 0.5 Gy IR
R and total cell lysatess collected 30 minutess post‐treatment.
Im
mmunoblottin
ng with anttibodies reco
ognizing phoosphorylated p53 at Seer15 indicatees no
difference in activation of the p53 pathw
way in lamins ‐deficient cellls.
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2.5 Defective repair of IR‐induced DSBs in lamins‐deficient cells
To determine the functional significance of decreased 53BP1 at IRIF in Lmna-/- cells, we
evaluated repair of IR-induced DSBs by performing neutral comet assays. Asynchronously
growing Lmna+/+ and Lmna-/- MEFs were treated with 8 Gy of IR, cells were collected at different
times post-IR, and the extent of DNA DSB repair evaluated by single cell gel electrophoresis
under neutral conditions [203]. Single cell gel electrophoresis results in a comet-shaped
distribution of DNA as fragments migrate away from the center of the nucleus. The comet head
contains high-molecular weight and intact DNA, and the comet tail contains the leading ends of
migrating fragments (Figure 20a). Olive moment, a quantification of the amount of DNA and its
distribution in the tail, is a measure of unrepaired DNA breaks [203]. When compared to wild-type
MEFs, lamin A/C-deficient cells had a higher olive moment at all times tested post-IR (Figure
20b). This indicated that DNA DSB repair was substantially compromised by loss of A-type
lamins.

The repair of DSBs after IR usually follows bimodal kinetics with fast and slow repair
phases [69]. There is substantial evidence implicating classical NHEJ as the major mechanism
used during the fast phase of DSBs repair, and alternative NHEJ or HR in the slow phase of
repair [204, 205]. This bimodal form of DNA DSBs repair is clearly observed in Lmna+/+
fibroblasts, such that the fast phase occurred within 60 minutes post-IR, followed by a relatively
slow phase of DSBs repair onwards (Figure 20B). However, Lmna-/- fibroblasts did not display this
fast phase of repair, requiring up to 150 minutes to repair the damage that could be repaired
within 30 - 60 minutes by the wild-type cells (Figure 20B). This indicated that the involvement of
A-type lamins in NHEJ extends beyond the scope of deprotected telomeres, being also applicable
to the repair of IR-induced DSBs.

To determine if 53BP1 could rescue the defective fast-phase of repair of IR-induced
DSBs in Lmna-/- MEFs, cells were retrovirally transduced with a 53BP1 construct or an empty
vector control (Figure 21A) and neutral comet assays were performed. While Lmna-/- fibroblasts
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Figure
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a-/- fibroblasts completely re
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Furtherm
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53BP1 in Lmn
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ot lead to a fu
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ells to repair D
DSBs (Figure 21B). Collecctively,
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t
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Fiigure 20. Defective repair of IR‐induced DNA DSBs upon loss of A‐type lamin
ns. Asynchron
nously
+/+
‐/‐
‐
grrowing Lmna and Lmna MEFs were
e irradiated w
with 8 Gy. At different times post‐irradiation
(0
0, 30, 60, 90, 120 and 150 min) cells we
ere collected and neutral comet assayss were performed.
(A
A) Representaative images of the comets. Note the ppresence of co
omet tails immediately aftter IR,
an
nd how the taails decrease with time, indicating activve repair of D
DSBs. (B) Kinetics of repair of IR‐
in
nduced DSBs as assessed by
b Olive Comet Moment, a measure off unrepaired DNA. A total of 25
to
o 30 cells werre analyzed per
p sample in each experim
ment. The aveerage ± stand
dard deviation of 4
in
ndependent experiments
e
is shown.
.
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Interpretation of these results is complicated by the fact that previous reports have
indicated dispensability of 53BP1 for repair of short-range DNA DSBs, along with our data
showing that depletion of 53BP1 in wild-type MEFs did not inhibit the fast-phase of repair (Figure
21C). We reason that 53BP1 deficiency in lamin A/C-deficient cells is not solely responsible for
the observed defects in the fast-phase of repair. Rather, it is the combined deficiency of A-type
lamins and 53BP1 which is responsible for the shift in the kinetics of DNA DSBs repair towards a
slower operating mechanism. This slower form of repair could represent a lower efficiency of CNHEJ or activation of an alternative mechanism of repair in lamins-deficient cells. In either case
the fact that reconstitution of 53BP1 restores normal kinetics of repair of IR-induced DNA DSBs
supports a role for 53BP1 in promoting C-NHEJ repair and inhibiting alternative mechanisms of
DNA DSBs repair.

2.6 DISCUSSION
Previous studies had shown that expression of mutant lamin A isoforms leads to alterations in the
DDR and defective repair, which translate into increased sensitivity to DNA-damaging agents
[152, 173, 206]. Prior to our studies the effect of complete loss of A-type lamins on DNA repair
mechanisms remained unknown. By demonstrating that TRF2∆B∆M -induced telomere fusions
require A-type lamins, we provided the first link between loss of A-type lamins and defective
NHEJ repair. The fact that mutations in the LMNA gene were previously associated with
increased NHEJ [152] indicates yet another functional difference between mutation and loss of Atype lamins. In light of a report showing that loss of 53BP1 inhibits processing of dysfunctional
telomeres by NHEJ [51], we hypothesized that destabilization of this protein in lamins-deficient
cells was in part responsible for the observed phenotype. In support of this hypothesis, our
reconstitution experiments clearly demonstrate that destabilization of 53BP1 upon loss of A-type
lamins is responsible for the defects in the processing of dysfunctional telomeres by NHEJ.
Interestingly, the telomeric NHEJ elicited by TRF2∆B∆M requires 53BP1 and DNA ligase IV,
indicating it as C-NHEJ, whereas the NHEJ elicited by removal of Tpp1-Pot1a/b, another shelterin
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Fiigure 21. 53B
BP1 rescues fast‐phase repair of IR‐i nduced DSBss in Lmna‐/‐ cells. (A) Weestern
blots to monitor the levels of 53BP1 pro
otein in Lmnaa+/+ and Lmnaa‐/‐ MEFs retro
ovirally transd
duced
with
w empty vector (EV) con
ntrol or a 53BP1‐expressingg vector. Sho
ort and long exposures of 5
53BP1
arre shown. Acctin levels are
e used as load
ding control. (B) Kinetics o
of repair of IR‐induced DSSBs as
asssessed by Olive
O
Comet Moment
M
in Lm
mna+/+ and Lm
mna‐/‐ MEFs rretrovirally trransduced wiith an
EV
V or a vecto
or encoding 53BP1. Approximately 225 to 30 cells were anallyzed per sample,
phase
normalized, an
nd the mean calculated.
c
Re
econstitutionn of 53BP1 in Lmna‐/‐ cells rescues fast‐p
epair, as opposed to exprression of an empty vectoor control. (C
C) Comet asssays performeed on
re
wild‐type
w
MEFFs with or witthout 53BP1 demonstratee that loss off 53BP1 (left panel) alonee does
not affect fast‐‐phase repairr of IR‐induced DNA DSBs ((right panel).
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In addition to the role of A-type lamins in long-range NHEJ, our studies demonstrate their
participation in short-range DSBs repair, as exemplified by the defects in the fast-phase of repair
of IR-induced DSBs. In mammalian cells DNA DSB repair occurs mainly by NHEJ and HR. NHEJ
is faster and more efficient than HR, but at the expense of low fidelity. Analysis of kinetics of
repair of IR-induced DNA DSBs has revealed two types of NHEJ. C-NHEJ represents the fast
component of DSB rejoining and relies on DNA-PK and the XRCC4/DNA Ligase IV complex [205,
208]. Although DNA-PK deficiency retards repair of DNA DSBs, damage is eventually repaired by
a slower operating mechanism, possibly A-NHEJ [204]. Given the dominance of the slow phase
repair in lamins-deficient cells we speculate that it might represent an upregulation of A-NHEJ in
lieu of decreased C-NHEJ. Interestingly reconstitution of 53BP1 in lamins-deficient cells was
sufficient to rescue the fast-phase repair of IR-induced DNA damage. While a whole body of
evidence indicates that 53BP1 participates in long-range DNA end-joining processes, such as
class switch recombination, V(D)J recombination, and chromosome end-to-end fusions, the role
of 53BP1 in short-range DSB repair is not clear [99]. Depletion of 53BP1 from wild-type cells
resulted in no change in their ability to complete the fast-phase of repair IR-induced DSBs. The
fact that 53BP1 was able to rescue fast-phase repair in Lmna-/- cells suggests that the role of
53BP1 in repair of IR-induced DSBs in wild-type cells is masked by a functional redundancy,
which is lost in A-type lamins-deficient cells. We speculate that loss of A-type lamins activates
compensatory mechanisms that repair DSBs with slower kinetics. Restoration of 53BP1 in this
context would then alter the balance between different DSBs repair pathways, tilting it in favor of
the fast-phase C-NHEJ. Future studies will address whether loss of A-type lamins is associated
with upregulation of other repair pathways, such as A-NHEJ.

Given the well established contribution of genomic instability to aging and cancer,
identifying the molecular mechanisms involved in maintaining genomic integrity is of utmost
importance. DNA DSBs repair, which occurs mainly by NHEJ and HR, is critical for maintaining
genomic stability. We have demonstrated that the structural nuclear proteins A-type lamins
preserve the integrity of the genome in part by maintaining the ability of cells to repair DNA DSBs
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by NHEJ. We also provide evidence that the mechanism which allows A-type lamins to promote
long-range (dysfunctional telomeres) and short-range (IR-induced DNA DSBs) classical-NHEJ is
the stabilization of 53BP1.
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Repression of Homologous Recombination in Lamins‐Deficient Cells
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ABSTRACT
In the previous chapters, we demonstrated a significant inhibition of the non-homologous
end-joining (NHEJ) pathway in lamins-deficient human and mouse cells. Lamins-deficient cells
exhibit decreased levels of 53BP1, an important NHEJ protein, due to post-translational
degradation. Increasing the levels of 53BP1 in lamins-deficient cells by exogenous expression or
inhibiting the degradation of the endogenous protein was sufficient to rescue NHEJ. To attain a
more complete understanding of how A-type lamins affect repair of DNA double strand breaks,
we investigated whether A-type lamins could affect homologous recombination (HR). Based on
the idea that different DSB repair pathways compete for repair substrate and recent reports
showing that 53BP1 is a potent inhibitor of HR, we hypothesized that decreased 53BP1 in lamin
A/C-depleted cells would lead to increased HR. Surprisingly, we find that depletion of lamins
significantly compromises HR by a mechanism involving transcriptional downregulation of BRCA1
and RAD51. Furthermore, we show that repression of BRCA1 and RAD51 requires p130, and
occurs in the context of decreased Rb and p107 protein levels. It was previously established that
loss of A-type lamins leads to proteasomal degradation of Rb and p107; however the exact
mechanism by which they become targeted for degradation remained an enigma. We provide
evidence that the cysteine protease Cathepsin L, which is upregulated in lamins-deficient cells
contributes to degradation of Rb and p107. In line with the DNA repair defects, lamins-deficient
cells exhibit increased radiosensitivity. This study demonstrates that A-type lamins promote
genomic stability by maintaining the levels of proteins with key roles in DNA DSBs repair by
NHEJ and HR, and reveals an unprecedented role for Cathepsin L in regulating Rb and p107.

3.1 Decreased HR in lamins‐deficient cells
To evaluate the proficiency of HR in lamins-deficient cells, we used a chromosomally
integrated reporter substrate, DR-GFP, in MCF-7 cells that were depleted of A-type lamins [209].
The DR-GFP substrate consists of two tandem GFP sequences that have both been mutated to
abrogate expression of GFP, and an Isce-I recognition site in one sequence. Transient
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Fiigure 22. A‐ttype lamins promote ho
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re
eduction in HR. (C) As a po
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3.2 Deficient recruitment of HR proteins to IRIF
To elucidate the molecular mechanisms behind HR defects in lamins-deficient cells, we
monitored recruitment of RAD51, an essential HR protein, to IRIF. We treated lamin A/C
proficient and deficient MCF-7 DR-GFP cells with 8 Gy of IR and performed immunofluorescence
to detect RAD51 foci 6 h post-IR. We found a significant decrease in the formation of RAD51 foci,
such that only 27% of shLmna cells scored positive for RAD51 IRIF, as opposed to 64% of the
shCtrl cells (Figure 23A and C). To ensure that our results were not cell type- or shRNA
sequence-specific, we performed acute depletion of A-type lamins in wild-type MEFs, using a
mouse-specific shRNA. Consistently, loss of A-type lamins led to a decrease in the formation of
RAD51 IRIF (Figure 23B). Next, we determined if upstream steps in the HR pathway were
affected by monitoring the formation of RPA IRIF. RPA binds to single stranded DNA (ssDNA),
which is formed during end-resection in homologous recombination, and can also be visualized
as foci by immunofluorescence staining. The presence of RPA foci is generally considered an
indication of successful DNA end-resection. As with the RAD51 IRIF we found a significant
reduction in the formation of RPA IRIF in the lamins-depleted cells (Figure 23D).

Interestingly, monitoring the levels of RAD51 by western blot revealed a marked
decrease of the protein in lamins-depleted cells. (Figure 24A). In contrast, global levels of RPA
were not affected by depletion of A-type lamins (Figure 24B). This indicated that another critical
upstream step in the HR process was affected. Since the formation of RPA foci reflects the
presence of ssDNA, we reasoned that DNA end-resection could be affected by loss of A-type
lamins. Based on the importance of BRCA1 in the formation of ssDNA we investigated whether
BRCA1 protein levels were also being affected by depletion of A-type lamins. We were surprised
to find that like RAD51, depletion of A-type lamins from MCF-7 cells was associated with a
significant reduction in BRCA1 protein levels (Figure 24B).
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Figure 23. Loss o
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to recoover for 6 hrrs before immunofluorescence
experim
ments to mon
nitor formation of RAD51
1 foci.
(A) Gra ph shows thee percentagee of MCF‐7 DR
R‐GFP
cells poositive for RA
AD51 foci (mo
ore than 10 ffoci in
the nuccleus). 200 ceells per condittion were anaalyzed
per expperiment. Thee average ± sstandard devviation
of 3 inddependent exxperiments iss shown. (B) MEFs
that arre depleted A‐type lamins also disp
play a
significaant reduction
n in their ability to form R
RAD51
IRIF. (CC) Representaative images of RAD51 foci in
MCF‐7 DR‐GFP cells. Blue im
mages show DAPI
stained
nuclei,
shows
green
R
RAD51
im
mmunofluore
escence. (D) Percent of cells positive forr formation o
of RPA2 foci.
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Fiigure 24. Deccreased exprression of RA
AD51 and BR
RCA1, but no
ot RPA2 in lamin A/C‐dep
pleted
ce
ells. (A) Westtern blots sho
owing the deccrease in globbal levels of R
RAD51 upon d
depletion of A
A‐type
laamins in both
h MCF‐7 DR‐‐GFP cells an
nd MEFs. β−ttubulin was used as a lo
oading contro
ol. (B)
BRCA1, an esse
ential HR pro
otein, is also severely
s
decreeased in lamiins‐deficient ccells. Howeveer this
bserved in another importtant HR proteein RPA2.
efffect is not ob

To dettermine the mechanism
m
be
ehind decreassed RAD51 a
and BRCA1 p
protein expresssion,
we
w performed
d qRT-PCR to determine
e if their mR
RNA levels w
were affecte
ed. Unlike 53
3BP1,
de
ecreased RA
AD51/BRCA1 was associa
ated with sig nificant decre
eases in mR
RNA levels (F
Figure
25
5A). This dec
crease in mRNA level was
s not a genera
al occurrence
e for HR prote
eins, as the m
mRNA
le
evels of RPA2
2 were not sig
gnificantly affected. A simiilar decrease in RAD51 tra
anscript levels was
allso observed in MEFs depleted of A-typ
pe lamins (Fig
gure 25B).

Previo
ous studies in
ndicated that under certa in stress con
nditions cells downregulatte the
ex
xpression of RAD51 and BRCA1
B
genes via transcriptional represssion by E2F
F4/p130 comp
plexes
th
hat bind to E2F sites in th
heir promoters [211, 212]]. The co-reg
gulation of BR
RCA1 and R
RAD51
ob
bserved upon loss of A--type lamins, together wi th the fact tthat lamins d
deficiency ind
duces
prrofound decre
eases in pRb
b and p107 le
evels with on
nly minor effe
ects in p130 ( [148] and F
Figure
26
6A) led us to hypothesiz
ze that this E2F4/p130
E
re
epressive complex might participate iin the
re
epression of RAD51 and BRCA1 genes. To test iif p130 was required for the transcrip
ptional
do
ownregulation
n of RAD51 upon
u
loss of A-type
A
laminss, we deplete
ed lamins in ccells double n
null for
-/pRb and p107
7 (DKO: Rb-/-;p107
;
) and in cells null ffor all three R
Rb family me
embers (TKO: Rb-/-
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p107-/-;p130-/-).
) Depletion of
o A-type lam
mins in DKO cells - proficcient in p130 - led to a m
marked
;p
de
ecrease in RAD51
R
protein
n levels (Figu
ure 26B). In ccontrast, dep
pletion of A-tyype lamins in
n TKO
ce
ells did not result in dow
wnregulation of RAD51 levels, indica
ating that p13
30 is require
ed for
do
ownregulation
n of RAD51 upon
u
loss of A-type
A
lamins..

Fiigure 25. Deccreased transscription of RAD51
R
and BR
RCA1, but no
ot RPA2 or 53
3BP1 in lamin
n A/C‐
depleted cellss. (A) qRT‐PCR to determine the mRNA
A transcript llevels of RPA
A2, RAD51, BRCA1,
an
nd 53BP1 in MCF‐7 cells. Note that lo
oss of A‐typee lamins lead
ds to a signifficant reductiion in
trranscripts of RAD51 and BRCA1,
B
but no
ot RPA2 or 533BP1. Shown are the averrages and standard
deviations fro
om three diffferent experriments. (B) qRT‐PCR in MEFs demonstrates a similar
decrease in RA
AD51 mRNA but
b not 53BP1
1 upon loss off lamin A/C.

To furtther investiga
ate the role of
o E2F4/p130 in RAD51 re
epression in lamin A/C defficient
ce
ells, we dete
ermined if dep
pletion of A-ttype lamins w
would promo
ote formation of the p130//E2F4
re
epressive com
mplex by perrforming co-im
mmunoprecip
pitation studie
es. Total cell lysates from
m wildty
ype MEFs we
ere subjected to immunop
precipitation w
with an E2F4 antibody, an
nd the presen
nce of
p130 monitore
ed by western
n blot. While depletion
d
of A
A-type laminss did not affecct the global levels
d the formatio n of p130/E2F4 complexes, as shown b
by the
off E2F4 (Figurre 26A and C)), it promoted
in
ncrease in p130 co-immun
noprecipitated
d with the E2F
F4 antibody ((Figure 26C).. The same results
were
w
obtained
d upon deplettion of A-type
e lamins in D
DKO cells, p
proficient in p
p130 (Figure 26D).
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clude that dep
pletion of A-ty
ype lamins prromotes the a
ability of p130
0 to form reprressor
Thus, we conc
omplexes witth E2F4, which in turn le
eads to dow
wnregulation o
of RAD51 an
nd BRCA1 g
genes,
co
re
esulting in deffective repair of DNA DSBs by HR.

Fiigure 26. Dow
wnregulation
n of RAD51 in
n lamin A/C‐ deficient cellls requires p130, a memb
ber of
th
he pocket fam
mily of proteiins. (A) Western blots shoowing alterations in expresssion of the p
pocket
faamily proteins in MCF‐7 DR‐GFP
D
cells and
a MEFs uppon depletion
n of lamin A/C. Note significant
decreases in Rb and p10
07, but not p130. Also note that expression of the repreessive
trranscription factor,
f
E2F4, remains uncchanged. (B) Western blo
ot showing deepletion of A
A‐type
‐/‐
‐/‐
‐/‐
‐/‐
laamins from MEFs
M
that are null for two (DKO:
(
Rb ; p 107 ) or all tthree (TKO: Rb ; p107 ; p
p130‐/‐
) of the pockett family prote
eins. Loss of lamins leads tto a dramaticc decrease of RAD51 only in the
ce
ells that are p130 proficient (DKO). (C) Co‐immunnoprecipitatio
on of p130 w
with E2F4. Lyysates
frrom lamin A//C –proficientt or –deficien
nt MEFs weree subjected to
o immunopreecipitation wiith an
E2
2F4 antibodyy. Western blots
b
(left) sh
hows successsful immunop
precipitation of E2F4, an
nd co‐
precipitation of
o p130. Note
e how loss of lamins leadss to increased
d pull down o
of p130. Inputs are
on the right. (D) Similar to
o (C), exceptt lysates werre obtained ffrom DKO MEFs. *Non‐sp
pecific
bands.
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The p130/E2F4 rep
pressor comp
plex is active
e primarily du
uring G0/G1 phases of th
he cell
ycle. In additiion, the levels
s of RAD51 and
a BRCA1 flluctuate durin
ng the cell cyycle, being red
duced
cy
du
uring G1 and
d upregulated at late G1, S,
S and G2 ph
hases of the ccycle. Thus w
we investigate
ed the
po
ossibility thatt p130/E2F4 mediated rep
pression occu
urs due to ch
hanges in the
e cell cycle p
profile
su
uch that depletion of A-ty
ype lamins would induce a growth arre
est in G1, w
which in turn w
would
in
ncrease p130//E2F4 repressor complex activity and re
repression of RAD51 and B
BRCA1 genes. We
us
sed flow cyttometry to analyze
a
the cell
c
cycle prrofile of pre--immortalized MEFs that were
le
entivirally tran
nsduced with
h a control shRNA
s
or an
n shRNA spe
ecific for A-tyype lamins. While
de
epletion of A--type lamins led
l to sharp decreases
d
in RAD51 levelss, it was not associated w
with an
at the
ac
ccumulation of
o cells in G1
1 phase of th
he cell cycle (Figure 27). These resultts indicate tha
efffect of depletion of A-type
e lamins on co
omponents o
of HR-mediate
ed repair is no
ot due to cell cycle
arrrest.

Fiigure 27. Losss of Laminss and Cell Cyycle Profile. (A) Western blots show decreased R
RAD51
protein in pre
e‐immortalize
ed wild‐type MEFs uponn depletion o
of A‐type lamins by lentiviral
trransduction with shLmnaa. (B) Decre
deficient cellls is not du
eased RAD511 in lamins‐d
ue to
allterations in cell cycle prrofile, as flow
w cytometry analysis dem
monstrates a similar cell cycle
profile in both the shLmna and shCtrl cells.

Altoge
ether, these data
d
demons
strate an unp
precedented role for A-tyype lamins iin the
transcriptional regulation of two key facto
ors in HR, BR
RCA1 and RA
AD51, in both mouse and h
human
ce
ells. Furtherm
more, neutral comet assay
ys performed in MCF7 DR
R-GFP cells d
depleted of A
A-type
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amins showed
d that these cells are also defective in fast-phase DNA repair (data not sh
hown).
la
Thus, we demonstrate nove
el roles for A-type lamins in the mainte
enance of facctors with keyy roles
n the repair off DSBs by botth NHEJ and HR.
in

3.4
3 Cathep
psin L reg
gulates de
egradatio
on of the rretinoblastoma tum
mor
suppresso
or protein
ns pRb and p107
Loss of
o A-type lam
mins leads to
o increased d
degradation o
of Rb and p
p107 [148]. T
This is
th
hought to occ
cur partly thro
ough the ability of A-type llamins to bin
nd and regula
ate the sub-nu
uclear
lo
ocalization of these proteins. However, the specifiic mechanism
m by which Rb and p10
07 are
ta
argeted for de
egradation rem
mains quite elusive,
e
being independentt of both MDM
M2 and gankyyrin, a
co
omponent of the 19S prote
easome subunit which is o
overexpressed
d in Lmna KO
O cells [165]. Given
ou
ur recent findings that CTSL
C
promote
es the degra
adation of 53
3BP1, we sp
peculated tha
at this
prrotease could be the missing link between
b
A-tyype lamins a
and Rb/p107 degradation
n. We
en
nvisioned a scenario
s
whe
ere CTSL-me
ediated degra
adation of Rb
b and p107 alters the ba
alance
be
etween the pocket
p
family
y proteins, lea
ading to incrreased forma
ation of p130
0/E2F4 complexes,
which
w
can in tu
urn mediate trranscriptional repression o
of BRCA1 and
d RAD51 and thus inhibit H
HR.

Figure
F
28. Re
egulation of R
Rb family meembers by CTTSL. Western‐blots
showing
s
thatt overexpresssion of CTSLL in wild‐typ
pe MEFs leads to
downregulati
d
on of the p ocket proteins pRb and p107 but haas no
effect
e
in the levels of p1300. Cells were rretrovirally trransduced witth am
empty
e
vector as a negativee control. As a positive control for increeased
CTSL
C
activityy, we show decreased llevels of 53
3BP1 in the CTSL
overexpressin
o
ng cells.
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To test our model we overexpressed CTSL in wild-type MEFs and monitored the levels of Rb
family members and RAD51. Indeed, we found that upregulation of CTSL was associated with a
substantial decrease in pRb and p107 but little effect on p130, mirroring the phenotype observed
in lamins-deficient cells (
Figure 28). These results demonstrate a novel role for CTSL in the regulation of the Rb family of
tumor suppressors. However, altering the levels of these proteins was not sufficient to induce
transcriptional repression of BRCA1 or RAD51 (data not shown), suggesting that A-type lamins
have additional roles in the regulation of transcription of these genes.

3.5 Loss of A‐type lamins increases radiosensitivity
Radiation therapy is a common modality in the treatment of cancer. IR preferentially kills repaircompromised cells, which are unable to deal with the extensive DNA damage generated. To
determine if loss of A-type lamins and the associated deficiency in 53BP1 and RAD51/BRCA1
affect sensitivity to IR, we performed colony formation assays. Lmna+/+ and Lmna-/- MEFs were
treated with increasing doses of IR up to 6 Gy, and their clonogenic capability assessed after 10
days in culture. The survival curves shown in (Figure 29) describe the relationship between the
radiation dose and the proportion of cells that retain reproductive integrity. In line with severely
compromised DNA repair, Lmna-/- MEFs were significantly more sensitive to IR than wild-type
controls.
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Figure 29 Lmna-/- MEFs display increased sensitivity to
ionizing radiation. Clonogenic survival in Lmna+/+ and
Lmna-/- MEFs in response to increasing doses of
radiation (0 to 6 Gy). Shown are the surviving fractions
and standard deviation of the mean from three
independent experiments.

3.6 DISCUSSION
We have shown that acute loss of A-type lamins leads to a severe compromise in HR.
These studies reveal an unprecedented role for A-type lamins in the transcriptional co-regulation
of two key factors in HR, RAD51 and BRCA1, by means of formation of p130/E2F4 repressor
complexes. Since BRCA1 associates with the MRN complex, which displays nucleolytic activity, it
is likely that HR-dependent end-resection itself is afflicted in lamins-deficient cells. This notion is
consistent with the defective recruitment of RPA to DNA DSBs in the absence of detectable
changes in the global levels of the protein. HR requires nucleolytic degradation of DNA ends to
generate 3’-ended ssDNA, a process mediated by MRN, CtIP and BRCA1 proteins. The ssDNA
generated by end-resection is rapidly bound by Replication Protein A (RPA), which removes
secondary structures in ssDNA and allows the formation of the RAD51 nucleoprotein filament that
drives DNA strand invasion and exchanges during HR [213]. BRCA1 also interacts with
phosphorylated CtIP, a protein that is involved in DNA end-resection and known to function in
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both HR and A-NHEJ [77, 81, 86, 214, 215]. Disrupting the interaction of BRCA1 with CtIP is
detrimental to HR, but does not affect A-NHEJ [215]. Thus, consistent with our discussion of Cversus A-NHEJ in lamin A/C deficient cells it is possible that loss of BRCA1 and RAD51 inhibits
HR, but does not affect the ability of cells to enact A-NHEJ. Overall, our data indicate a that Atype lamins promote the major mechanisms of DNA repair by contributing to the stability of
53BP1 protein and transcription of BRCA1/RAD51 genes. Unravelling which mutations in A-type
lamins affect levels of CTSL, destabilize 53BP1 and Rb family members and/or transcriptionally
regulate RAD51/BRCA1 will allow us to predict which lamins-related diseases present with
defects in specific mechanisms of DNA repair. The connection between CTSL and cellular levels
of Rb and p107 is particularly interesting since upregulation of CTSL has been associated with a
number of cancers. It will be useful to determine if CTSL plays a role in regulation of Rb/p107
under normal physiological conditions, and elucidate the exact mechanism by which upregulation
of CTSL causes decreased Rb/p107 proteins.
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SUMMARY
S
Y OF THE THESIS
Severa
al lines of evidence indicatte that not on
nly are A-type
e lamins silencced or upregu
ulated
in
n a variety of human canc
cers, but that these chang
ges significan tly impact pa
atient outcome [14,
15
5, 150]. Furth
hermore, mutations in A-ttype lamins llead to a varriety of dege
enerative dise
eases,
so
ome of which are characte
erized by prem
mature aging phenotypes a
and genomic instability. A major
ch
hallenge is to
t identify and
a
characterize the mo
olecular mech
hanisms thatt underlie la
aminsas
ssociated pathogenesis. To
T advance this field, I e
evaluated the
e role of A-ttype lamins iin the
maintenance
m
of
o genomic sta
ability in mouse and huma
an cells. Chap
pter one demo
onstrated a ro
ole for
A-type
A
lamins in telomere homeostasis
s, such that loss of lamin
n A/C is asso
ociated with gross
allterations in the
t
nuclear distribution
d
off telomeres, a
along with te
elomere attritiion and epige
enetic
ch
hanges at the
e telomeres.

Fiigure 30. Mo
odel depictingg the effect of
o A‐type lam
mins on the D
DNA damagee repair pathw
ways.
A‐type lamins stabilize the
e pocket family proteins ppRb and p107, as well ass the NHEJ prrotein
53
3BP1, by inhibiting CTSL‐mediated degradation. Byy stabilizing 553BP1, A‐typ
pe lamins pro
omote
classical‐NHEJ.. The lamins‐aassociated altterations in tthe pocket family proteinss lead to increeased
fo
ormation of p130/E2F4 complexes,
c
which
w
can inn turn bind the RAD51 and BRCA1 gene
promoters and
d inhibit theirr transcription
n. Thus, loss of A‐type lam
mins leads to defects in the two
major
m
mechan
nisms of DN
NA DSBs repaair (NHEJ annd HR), increeased genom
mic instabilityy and
raadiation sensiitivity.
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In chapter two, I focus on the role of A-type lamins in non-homologous end-joining (NHEJ),
showing that A-type lamins are necessary for both long- and short-range NHEJ. I demonstrate
that the mechanism by which loss A-type lamins inhibits NHEJ is via destabilization of 53BP1. In
chapter three, I show that loss of A-type lamins leads to inhibition of homologous recombination
(HR) of DSBs due to transcriptional repression of BRCA1 and RAD51 by the 130/E2F4 complex.
Importantly, these studies led to our discovery of novel roles for the cysteine protease CTSL in
regulating the stability of both 53BP1 [187] and the retinoblastoma pocket family proteins. The
findings are summarized in the model (Figure 30).
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4.1 Nuclear organization of telomeres
Telomeres are nucleoprotein structures that protect the ends of eukaryotic chromosomes
[216-218]. A minimal length of telomeric DNA repeats and proper binding of specialized proteins
such as shelterin complex components and DNA repair factors are required for the maintenance
of telomere structure and function [40]. Similarly, acquisition of a heterochromatic structure at
mammalian telomeres is critical for the control of telomere homeostasis [219]. The importance of
telomere compartmentalization for telomere function has been clearly demonstrated in yeast
[177]. In Saccharomyces cerevisiae or budding yeast, telomeres are clustered in foci at the
nuclear periphery [220, 221]. At least two redundant mechanisms have been identified that
mediate tethering of telomeres to the periphery. One mechanism involves yKu70/Ku80
heterodimer, which associates with the telomerase complex Est1/Est2/Tlc1, and an integral inner
nuclear membrane protein of the SUN domain family, Mps3 [222, 223]. A second mechanism
involves the histone deacetylase Sir4, which binds to the inner nuclear membrane-associated
protein Esc1 (Enhancer of silent chromatin 1) [224-226]. Importantly, disruption of the tethering of
telomeres to the nuclear periphery leads to deprotection and hyper-recombination of telomeres
[223], and derepression of subtelomeric genes [177]. In the case of Sir4, inactivating mutations
also involve telomere shortening [227], suggesting a link between telomere localization at the
nuclear periphery and maintenance of length homeostasis.

Mammalian telomeres do not accumulate at the nuclear periphery, except during meiosis
[228]. They are distributed throughout the entire nucleoplasm in G1 and S phases of the cell
cycle, while assembling in the center of the nucleus during G2 in preparation for mitosis [166]. It
has been proposed that interactions between telomeres and the nuclear matrix determine their
localization in the nuclear space [229, 230]. Tracking 3D trajectories of fluorescently labeled
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telomeres in a broad time range has provided new information about telomere dynamics within
the nucleus. At short time scales, the diffusion of telomeres is anomalous, while at longer time
scales a normal diffusion is observed with a wide distribution of diffusion constants. This transient
anomalous diffusion was explained by the existence of a local binding or obstruction mechanism
to telomere mobility [231]. To date, the molecular mechanisms that orchestrate nuclear tethering
and localization of mammalian telomeres, and their relevance for telomere metabolism remain
unknown [232].

Interestingly, the 3D organization of telomeres is altered in tumor cells [166, 167], and in
senescent cells that present defects in the nuclear lamina [168].

This data suggests a

relationship between changes in nuclear distribution of telomeres and the alterations of telomere
metabolism observed during senescence and immortality. We have shown that A-type lamins
bind to mouse telomeres and participate in their nuclear compartmentalization. Embryonic
fibroblasts from LMNA null mice exhibit changes in the nuclear distribution of telomeres towards
the nuclear periphery and away from the nuclear center. This was unexpected, since lamins are
highly enriched at the nuclear periphery. However, while B-type lamins are exclusively found at
the nuclear periphery, lamins A and C are proposed to form part of a filamentous meshwork that
expands throughout the entire nucleoplasm. We speculate that A-type lamins actively participate
in the distribution of telomeres throughout the nucleus. In the absence of A-type lamins, proteins
at the nuclear periphery such as B-type lamins, inner nuclear membrane proteins or nuclear pore
complex proteins, could undertake the tethering of telomeres. In this model, the nuclear periphery
would represent a default pathway for telomere distribution, which would resemble telomere
localization in yeast, which do not express lamins. This model is supported by a 2010 study in
which Winnok H. De Vos and colleagues demonstrated hypermobility of telomeres in human
fibroblasts that lack expression of lamin A/C. This study supports the idea that A-type lamins help
tether telomeres throughout the 3D nuclear space.
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Further studies need to characterize the molecular determinants of the association of Atype lamins with telomeres. A-type lamins can bind directly to DNA-chromatin and indirectly via
their interaction with lamin-associated proteins such as LAP-2α, emerin and MAN1 [12, 233].
Although

we

found

that

A-type

lamins

bind

telomeric

sequences

by

chromatin

immunoprecipitation, we do not know whether the interaction is direct or mediated by laminassociated proteins. LAP-2α is of special interest given that it binds to telomeres during nuclear
reassembly after mitosis [234]. In addition, LAP-2α mediates the interaction of Rb with A-type
lamins, contributing to the stabilization of Rb family function [235], and is the only member of its
family that is localized throughout the nucleoplasm. All these characteristics make LAP-2α a good
candidate for mediating tethering of telomeres to A-type lamins. From the telomere end, it is
possible that components of the shelterin complex associate with A-type lamins or laminassociated proteins localized at the nucleoplasm. Alternatively, A-type lamins might recognize
heterochromatic features at the telomere. Heterochromatin Protein 1 (HP1) has been shown to
form a complex with A-type lamins and LAP-2α [236], and therefore could participate in the
tethering of heterochromatic domains such as telomeres and centromeres to the scaffold of Atype lamins.

4.2 A‐type lamins and telomere structure, length and function
The first evidence supporting a role for A-type lamins in telomere biology came from
studies of patients with Hutchinson Gilford Progeria Syndrome. HGPS or progeria is a premature
aging disease caused by a mutation in the LMNA gene that generates a truncated lamin A
isoform known as progerin, which is toxic for the cell [140, 155]. HGPS fibroblasts were shown to
undergo faster telomere attrition during proliferation than normal counterparts [22, 141].
Fibroblasts from HGPS patients and aged individuals also present defects in epigenetic marks
characteristic of constitutive heterochromatin, although the effect on telomeres was not tested
[173, 174]. The mechanism by which mutation in the LMNA gene resulting in the expression of
progerin leads to telomere shortening remains unknown. Additional evidence of a crosstalk
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between A-type lamins and telomeres was provided by studies showing that telomerase rescues
proliferative defects of human fibroblasts expressing lamin A mutants [237], and that senescenceassociated alterations of the nuclear lamina are accompanied by aggregation of telomeres to the
nuclear lamina [168].

Despite the importance of telomere maintenance for cancer progression, the impact that
the loss of A-type lamins that characterizes certain tumor types has on telomere biology remained
undetermined. Our study using LMNA knock-out mouse fibroblasts as a model revealed that Atype lamins play a key role in the maintenance of telomere structure, length and function.
Telomeres in Lmna-/- mice are consistently shorter than the corresponding wild-type controls, and
exhibit an increase in signal-free ends (loss of telomeric signals). Furthermore, acute depletion of
A-type lamins by shRNAs specific for depletion of lamins A and C, leads to telomere shortening
after only a few passages of the cells in culture as determined by Quantitative Fluorescence In
Situ Hybridization (Q-FISH) with a telomeric probe. Most importantly, reintroduction of either
lamin A, lamin C, or both by retroviral transduction rescued the telomere shortening phenotype.
Reintroduction of lamins significantly increased the average telomere length and was associated
with a decrease in the pool of short telomeres, and an increase in the pool of long telomeres.
These data indicate that A-type lamins play a key role in the control of telomere length. However,
we do not know the mechanism behind the telomere shortening phenotype observed in A-type
lamins-deficient cells. The levels of telomerase activity and the binding of the shelterin complex
components TRF1 and TRF2 were not affected by the loss of A-type lamins. Similarly, we did not
observe any evidence of aberrant recombination at telomeres, which could explain the loss of
telomeric sequences. It is possible that the binding of other shelterin complex components or
DNA repair factors with a function at the telomere could be defective in LMNA null cells.
Alternatively or concomitantly, loss of A-type lamins might hinder the accessibility of telomerase
or other proteins implicated in telomere metabolism, especially factors implicated in telomere
replication.
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Maintenance of a heterochromatic structure at telomeres is also critical for the control of
telomere length. Previous studies demonstrated that loss of heterochromatic features such as
methylation of histones H3 and H4 at different lysine residues and methylation of subtelomeric
DNA results in a pronounced telomere elongation phenotype [56, 232, 238, 239]. In most cases,
telomere elongation correlated with an increase of telomere sister chromatid exchange (T-SCE)
events, characteristic of the activation of Alternative Lengthening of Telomeres (ALT) pathway of
telomere maintenance [32, 240]. We found that loss of A-type lamins resulted in decreased
levels of the heterochromatic mark H4K20me3 -histone H4 trimethylated at lysine 20-. This defect
is likely due to the fact that Rb family members, which have a known role in the stabilization of
this chromatin modification, are targeted to degradation by the proteasome upon loss of A-type
lamins [148]. However, contrary to the telomere elongation phenotype characteristic of Rbdeficient cells [171, 241] and H4K20me3- deficient cells (Suv4-20h double knock-out) [55], the
loss of Rb or decrease in H4K20me3 was not sufficient to trigger telomere elongation in the
context of A-type lamins deficiency.

Thus, A-type lamins, or a process regulated by these

proteins, are necessary for the elongation of telomeres upon loss of Rb family members and
decrease of H4K20me3.

Interestingly, depletion of A-type lamins in U2OS cells, an

osteosarcoma cell line which relies on ALT for telomere maintenance, did not lead to any
significant alterations in telomeric sister-chromatid exchange, indicating that loss of A-type lamins
is sufficient to inhibit ALT that is associated with alterations in histone methylation.

4.3 Mechanisms of DNA DSBs repair
Repair of damaged DNA is critical for maintenance of genomic stability. Among the
various types of DNA damage, DSBs are the most deleterious, leading to mutations, loss of
genomic material, and translocations if not properly repaired. The two major pathways of DSBs
repair, homologous recombination (HR) and classic non-homologous end-joining (C-NHEJ) are
considered to compete for repair substrate [62, 90]. HR is error-free and requires both resection
of the 5’ DNA ends around the break and the presence of a homologous template. In contrast,
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ligation of damaged DNA during C-NHEJ requires neither extensive resection nor homologous
templates. C-NHEJ is a fast and error-prone mechanism which can cause translocations and/or
loss of genetic material. While C-NHEJ is the predominant repair mechanism in G0/G1 stages of
the cell cycle, when the lack of the sister chromatid prevents HR from being used, the slower HR
repair mechanism has traditionally been thought to dominate during S and G2 phases of the cell
cycle. Recent evidence has challenged the notion of HR dominance in S/G2, suggesting that the
need for rapid DNA damage repair makes NHEJ the preferred pathway even when HR is possible
[92]. According to this data it is only when the damage cannot be repaired by NHEJ that endresection is promoted and additional mechanisms undertake DNA repair. Besides HR and CNHEJ, a less understood pathway, alternative non-homologous end-joining (A-NHEJ), is
sometimes used as a backup repair pathway [69, 242]. A-NHEJ involves processing of DNA by
end-resection to reveal regions of microhomology which are then ligated. In contrast to HR,
resected DNA is not filled in during A-NHEJ, making it a more deleterious process than both CNHEJ and HR. In line with this notion, A-NHEJ is associated with high frequencies of
chromosomal translocations and genomic instability.

4.4 A‐type lamins and DNA repair
Expression of mutant lamin A isoforms is associated with defective DNA repair.
Fibroblasts from HGPS patients and from a mouse model of progeria generated by depletion of
the metalloproteinase responsible for the maturation of prelamin A (Zmpste24 knock-out) [152,
158] have alterations in the DDR. In particular, these cells exhibit increased DNA damage and
chromosome aberrations and are more sensitive to DNA-damaging agents. At a molecular level,
HGPS and Zmpste24-/- MEFs showed a delayed recruitment of 53BP1 to phosphorylated histone
H2AX (γ-H2AX)-labeled DNA repair foci upon induction of DNA damage, and a delayed
disappearance of these foci. Zmpste24-/- MEFs also showed impaired recruitment of RAD51 to
sites of DNA damage leading to a delayed checkpoint response and defective DNA repair [152].
Furthermore, ectopic expression of mutant forms of lamin A in the presence of wild-type lamin
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A/C diminished the cellular ability to form γ-H2AX-labeled DNA repair foci in response to mild
doses of cisplatin or UV irradiation, and mislocalized ATR kinase, a key sensor in DDR [161].
More recent studies have demonstrated that fibroblasts from HGPS patients and from Zmpste24-/MEFs display an activated DNA damage response, as evidenced by enhanced γ-H2AX, and
activation of the p53 pathway [160, 173]. All these reports suggest that unprocessed prelamin A
and truncated lamin A act in a dominant negative fashion to perturb DNA damage response and
repair.

Elucidating the specific steps of these processes that are affected in the different

laminopathies could bring about new possibilities for treatment.

4.5 A‐type lamins affect 53BP1‐dependent NHEJ of telomeres
Our study shows that LMNA null fibroblasts exhibit signs of genomic instability: higher
incidence of chromosome and chromatid breaks, increased numbers of signal free ends
(telomere loss), and basal levels of unrepaired DNA, as shown by the presence of cells labeled
with γ-H2AX. These data indicate that not only mutant forms of lamins, but also depletion of Atype lamins affects the ability of cells to properly deal with DNA damage. Nevertheless, the
different mutations and the changes in expression of A-type lamins are expected to have different
consequences for nuclear function, given the variety of diseases associated with the different
alterations. Establishing for example, if tumor cells in which the LMNA promoter is silenced by
DNA methylation are defective in DNA repair and more sensitive to DNA damaging agents, would
provide valuable information towards the use of lamins as targets for cancer therapeutics.

Loss of telomere integrity activates a classical DDR characterized by the activation of the
ATM/p53 pathway and the formation of DNA damage foci at telomeres [185]. These telomere
dysfunction-induced foci (TIF) contain many DNA damage response proteins, including γ-H2AX,
53BP1, MDC1, and MRN complex, and are established as a read-out of telomere damage.
Activation of ATM/p53 is followed by the processing of dysfunctional telomeres by the NHEJ
repair pathway, leading to chromosome end-to-end fusions [186]. Two recent studies have shown
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that deprotected telomeres are more mobile and sample larger territories within the nucleus than
functional telomeres [51, 243]. Dimitrova et al. presented evidence about 53BP1 playing an active
role in chromatin dynamics, such that it facilitates the association and fusion of dysfunctional
telomeres that might be far away within the nucleus [51]. Our study shows that chromosome endto-end fusions of dysfunctional telomeres, induced by the expression of a dominant negative
TRF2 protein, require A-type lamins, providing the first link between loss of A-type lamins and
defective NHEJ repair. In addition, we demonstrated that the mechanism of inhibition of telomere
NHEJ was due to the destabilization of 53BP1 in lamin A/C-deficient cells. It is possible that in
addition to maintaining 53BP1 stability, A-type lamins play an active role in the DDR and in the
53BP1-mediated regulation of mobility and NHEJ of dysfunctional telomeres. In 2010 Winnok H.
De Vos and colleagues demonstrated intranuclear hypermobility of telomeres in human
fibroblasts that lack expression of lamin A/C [244]. Based on this report, increased mobility of
telomeres in the Lmna-/- fibroblasts should circumvent the need for 53BP1 for efficient fusion;
however we still see decreased telomere fusions in these cells, arguing against the 53BP1mediated telomere mobility hypothesis.

4.6 A‐type lamins affect NHEJ of ionizing radiation‐induced DSBs
Despite the increase in genomic instability, similar to what was reported in progeria cells,
loss of A-type lamins does not impair activation of the DNA damage response (DDR) when cells
are exposed to ionizing radiation. ATM-dependent phosphorylation of H2AX and p53 at Ser15
was not affected in Lmna-/- mouse embryonic fibroblasts (MEFs), and the kinetics of formation
and resolution of γ-H2AX ionizing radiation-induced foci (IRIF) was indistinguishable between
lamins-deficient and –proficient cells In contrast, lamins-deficient cells showed defective
accumulation of 53BP1 at IRIF at all post-irradiation times tested. Importantly, this deficiency was
due to the decrease in 53BP1 and not to failed recruitment, since 53BP1 IRIF formed although at
a much lower intensity. These data, together with the fact that 53BP1-deficient cells exhibit
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increased genomic instability and radiosensitivity suggested that the loss of 53BP1 could be
responsible for the DNA repair deficiencies observed in lamin A/C-deficient cells.

Consistent with our hypothesis, lamins-deficient cells treated with ionizing radiation had
profound defects in the fast phase of DNA DSBs repair. Fast repair is traditionally associated with
C-NHEJ, since similar defects are observed upon depletion or mutation of essential factors in this
process such as DNA-PK, Ku80, XRCC4, and DNA ligase IV. Importantly, we found that
reconstitution of 53BP1 in lamins-deficient cells rescues the defects in NHEJ of DNA DSBs and
dysfunctional telomeres. Overall, these results revealed that 53BP1 deficiency is a major
contributor of the DNA repair phenotype observed in lamins-deficient cells. This is a critical
observation, since many studies rely on foci formation to determine whether a step in the DDR is
functional. Our results indicate that it is important to monitor the levels of DDR proteins at DSBs
when assessing deficiencies in DNA repair.

4.7 How are the levels of 53BP1 regulated by A‐type lamins?
During our exploration of mechanisms by which A-type lamins affect DNA DSBs repair
our group discovered a role for cathepsin L (CTSL) in the stability of 53BP1 protein. The first link
between CTSL and A-type lamins was established in a mouse model of progeria [160]. In
particular, mice lacking Zmpste24, a metalloprotease that participates in the maturation of lamin
A, exhibit a drastic increase in the levels of CTSL mRNA. Although this suggested a relationship
between CTSL and the aging phenotype, no association was established between CTSL and the
increase in genomic instability displayed by these mice. Our studies showed that Lmna-/- cells
also exhibit a marked increase in the levels of CTSL mRNA and protein [187], indicating that loss
of A-type lamins induces transcriptional upregulation of CTSL. Furthermore, we show that
upregulation of CTSL leads to a dramatic downregulation of 53BP1 protein levels. Since many
cancers present with high CTSL expression [190-192, 245, 246], these studies indicate
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suppression of DSBs repair as an important mechanism by which CTSL contributes to
tumorigenesis.

4.8 Lamins role in DNA DSBs repair by HR
Loss of 53BP1 favors repair of DNA DSBs by HR [89, 90]. However, despite decreased
53BP1 levels, we found that HR was suppressed upon depletion of A-type lamins. Inhibition of
HR is explained by the significant reduction in expression of two key factors in this process,
BRCA1 and RAD51. In contrast to the CTSL-mediated degradation of 53BP1, decreased levels of
BRCA1 and RAD51 were brought about by transcriptional repression. Previous reports had
demonstrated transcriptional repression of BRCA1 and RAD51 under certain stressful conditions,
such as hypoxia or PARP inhibition, via formation of p130/E2F4 complexes at E2F sites within
their promoters [211, 212]. We found that repression RAD51 and BRCA1 genes in laminsdeficient cells was linked to the status of members of the Rb family of tumor suppressors (Rb,
p107 and p130) - repression of BRCA1 and RAD51 required p130 and occurred in the context of
decreased levels of Rb and p107. Furthermore co-immunoprecipitation studies in cells depleted
of A-type lamins showed an increase in the formation of p130/E2F4 complexes. These data
suggest activation of a repressive mechanism in lamins-deficient cells, where altering the balance
of the pocket proteins favors association of p130 with E2F4, leading to transcriptional inhibition of
responsive promoters. However, we cannot rule out the possibility that loss of A-type lamins
leads to alterations in the nuclear localization of BRCA1 and RAD51 genes, which might
contribute to their transcriptional repression.

It is well established that pocket proteins associate with lamins and that loss of A-type
lamins leads to increased degradation of Rb and p107 [148]. This is thought to occur partly
through the ability of A-type lamins to regulate the sub-nuclear localization of these proteins.
However up until now, the specific mechanism by which Rb and p107 are targeted for
degradation remained quite elusive, being independent of both MDM2 and gankyrin, a
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component of the 19S proteasome subunit which is overexpressed in Lmna KO cells [165]. Given
our recent findings that CTSL promotes the degradation of 53BP1, we speculated that this
protease could be the missing link between A-type lamins and Rb/p107 degradation. We
envisioned a scenario where CTSL-mediated degradation of Rb and p107 alters the balance
between the pocket family proteins, leading to increased formation of p130/E2F4 complexes,
which can in turn mediate transcriptional repression of BRCA1 and RAD51 and this inhibit HR. To
test our model we overexpressed CTSL in wild-type MEFs and monitored the levels of Rb family
members, BRCA1 and RAD51. Indeed, we found that upregulation of CTSL was associated with
a substantial decrease in pRb and p107, with little effect on p130, mirroring the phenotype
observed in lamins-deficient cells. These results demonstrate a novel role for CTSL in the
regulation of the retinoblastoma family of tumor suppressors. However, altering the levels of
these proteins was not sufficient to induce transcriptional repression of BRCA1 or RAD51,
suggesting that lamins have additional roles in the regulation of transcription of these genes.

Upregulation of CTSL is featured in a variety of cancers. Given the important role of Rb
as a tumor suppressor, it is likely that overexpression of CTSL represents yet another mechanism
by which tumor cells escape cell-cycle arrest. Furthermore, upregulation of CTSL and the ensuing
degradation of 53BP1 would compromise C-NHEJ and lead to genomic instability. Thus
upregulation of CTSL increases genomic instability by hindering DDR, yet impedes one of the
major cell cycle checkpoints responsible for ensuring genomic stability [247] by promoting
degradation of pRb. This double-blow to the integrity of the genome supports a significant role for
CTSL in tumorigenesis. Importantly, we have not identified the mechanism by which loss or
mutation of A-type lamins leads to transcriptional upregulation of CTSL. Given that alterations in
A-type lamins causes gross alterations in 3D distribution of chromatin, it is possible that increased
transcription of CTSL is a result of altered nuclear localization. It will be interesting to manipulate
nuclear positioning of the CTSL gene and test how this affects its transcription.
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4.10 Concluding remarks
While A-type lamins are implicated in wide a variety of human diseases, including
premature aging syndromes and cancer, little is known about the molecular mechanisms that
contribute to their pathogenesis. Here, I have presented our findings that loss of A-type impacts
telomere homeostasis and the two major pathways of repair of DSBs, NHEJ and HR. Additionally,
our studies on A-type lamins have led to the discovery of CTSL as a novel regulator of 53BP1
and the retinoblastoma pocket family proteins, suggesting a fundamental role for CTSL in the
regulation of cell cycle progression and DNA repair. These novel findings provide a significant
contribution to understanding the molecular mechanisms that contribute to genomic stability, and
advance our understanding of cancer, aging and laminopathic mutations

The findings that depletion of A-type lamins impairs DNA repair and induces
radiosensitivity, along with clinical data indicating that lamins expression can affect prognosis in
certain malignancies, introduces the possibility of using these proteins as targets for cancer
therapeutics. In addition, identification of 53BP1, RAD51 and BRCA1 as molecular targets of Atype lamins provides new tools to screen disease-associated mutations in the LMNA gene for
defects in DNA repair and genomic instability, which could contribute to their pathophysiology
.
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Cell Culture
Lmna+/+ and Lmna-/- MEFs and adult fibroblasts were generated in the laboratory of Colin
L Stewart as described by Sullivan et al [151]. Rb family-deficient MEFs were generated in the
laboratory of Julien Sage (Stanford University, CA). MCF-7 and U2OS cells were obtained from
ATCC (Manassas, VA). The MCF-7 DR-GFP cell line was previously described [248]. All lines
were maintained in DMEM-Glutamax (Invitrogen) supplemented with 10% bovine growth serum,
antibiotics, and antimycotics. For cycloheximide and proteasome inhibitor treatments, 0.5 106
cells were cultured for 6 h in media containing 10 g/ml cycloheximide, 30 M MG-132 (EMD
Biochemicals) or EtOH as control.

Chromatin Immunoprecipitation (ChIP)
ChIP analyzes were carried out exactly as described [54]. Chromatin extracted from Cells
cultured to 70-80% confluency in 150mm plates and subjected to immunoprecipitation with
various antibodies. Chromatin isolation: Adherent cells were treated for 15minutes at room
temperature (rt) with 1% formaldehyde/PBS to crosslink protein and DNA. Crosslinking was
terminated by the addition of glycine (final concentration 0.125 – 0.150 M) for 5 minutes. Cells
were then washed once with PBS, and then transferred (by scraping with ice-cold
PBS/PMSF/protease inhibitor cocktail) to 50ml falcon tubes. Cells were kept on ice from this point
on. Cells were pelleted and the lysed with a solution of lysis buffer (below) with PMSF/protease
inhibitors for 10 minutes on ice, and then sonicated to obtain DNA fragments between 250 and
1000 base pairs. Sonication was done in a bioruptor at 30 second intervals for 15 minutes at high.
After centrifugation of the sonicated mixture (14, 000 rpm for 15 minutes at rt), the supernatant
containing the chromatin was collected and the pellet was discarded.

Immunoprecipitation: 200 μl of the lysates was transferred to a 2ml eppendorf tube and

diluted 1/10 in dilution buffer (below) with PMSF/protease inhibitors and then pre-cleared
with 40μl of salmon sperm/protein A/G agarose beads (Upstate# 16-157) for 5 hours at
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4oC on a rotating platform. The supernatant was recovered by centrifuging the mixture at
rt for 4 minutes, 4000 rpm. Next, 4μg of the antibody of interest was added to the
solution, followed by incubation at 4oC for 1hr. 60 μl protein A/G beads was added to the
solution, which was then incubated at 4oC overnight on a rotating platform. The solution
was centrifuged and the supernatant stored on ice as the unbound fraction for later use
as inputs. The pelleted fraction, containing the beads, was washed with a series of wash
buffers (detailed below): once in low salt immune complex wash buffer, once in high salt
immune complex wash buffer, once in LiCl immune complex wash buffer, twice in TE
buffer. 2ml of the respective buffers was used for the each wash, which was done for
4minutes at rt on a rotating platform. Elution of the immune complexes was done by
adding 250μl of elution buffer (below), vortexing at rt slowly for 15, followed by
centrifugation at 4000 rpm for 4 minutes. The eluate was transferred to a separate tube,
and the elution procedure repeated once more. The eluates were combined to get
≈500ul containing the bound fraction. We then reversed the crosslinks by adding 20μl of
5M NaCl and incubating at 65oC overnight (inputs were included at this step).

DNA Recovery: To remove RNA and proteins we added 10μl of 0.5M EDTA, 20 μl 1M

Tris-HCl pH 6.5, 2 μl RNase (10 μg/ μl), 2 μl proteinase K (20 μg/ μl) to each sample,
and incubated at 45oC for 1hour. DNA was then recovered by phenol/chloroform
extraction and ethanol precipitation. 500 μl chloroform: isoamyl alcohol 24:1 was added
and the solution vortexed on high, then centrifuged at rt for 5 minutes at 10, 000 rpm in a
tabletop centrifuge. The supernatant was transferred to a 2ml eppendorf tube in which
we added 50 μl 5M NaCl, 1.5 ml ethanol and 1 μl glycogen, followed by incubation at 20oC for an hour to precipitate the DNA. After centrifuging this mixture for 15 minutes at
14, 000 rpm we washed the pellet with 70% ethanol. The pellet was allowed to air dry
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and then resuspended in 30 μl TE buffer. DNA was then slot-blotted on a Hybond N+
membrane and hybridized to a telomeric probe (gift from T de Lange, Rockefeller
University, NY, USA) or a major satellite probe. The quantification of the signal was done
using the ImageQuant software (Molecular Dynamics). We calculated the amount of
telomeric or pericentric DNA immunoprecipitated relative to the signal of the
corresponding inputs. In all cases, we represented the ChIP values as a percentage of
the total input telomeric DNA, therefore correcting for differences in the number of
telomere repeats.

The following antibodies were used for chromatin immunoprecipitation:
Anti-H3K9me3 (#07-442, Upstate); anti-H4K20me3 (#07-463, Upstate); anti-TRF1 (T1948,
Sigma); anti-TRF2 (#05-521, Upstate); or anti-lamin A/C (SC-6215, Santa Cruz).

ChIP solutions:
Lysis buffer: 1% SDS, 10mM EDTA, 50 mM Tris-HCl pH8, protease inhibitor cocktail.
Dilution buffer: 1.1% Triton X-100, 0.01% SDS, 1.2 mM EDTA pH 8.0, 167 mM NaCl, 16.7 mM
Tris-HCl pH 8, protease inhibitor cocktail.
Low salt immune complex wash buffer: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM Tris-HCl
pH 8, 150 mM NaCl.
High salt immune complex wash buffer: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM TrisHCl pH 8, 500 mM NaCl.
LiCl immune complex wash buffer: 0.25M LcCl, 1% NP-40, 1% deoxycholateNa, 1mM EDTA, 10
mM Tric-Hcl ph 8.
Elution buffer: 1% SDS, 50 mM NaHCO3
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Immunoprecipitation, Immunoblotting and Immunofluorescence

Immunoprecipitation of Rb family members.
Cells were lysed in RIPA buffer (0.15 M NaCl, 0.05 M Tris–HCl pH 7.2, 1% Triton-X 100,
1%

sodium deoxycholate,

and

0.1%

SDS),

sonicated

and

1

mg of

total

protein

immunoprecipitated with antibodies bound to protein A-agarose beads: Rb (IF18), p107 (C-18),
and p130 (C-20) from Santa Cruz. Protein detection was carried out using antibodies against Rb
(BD Pharmingen), p107 and p130 (Santa Cruz).

Immunoblotting
For immunoblotting, cells were lysed in RIPA buffer. Protein detection was carried out
using the following antibodies: Lamin A/C (SC-6215, 20681 Santa Cruz), actin (Clone C4, MPB), tubulin (Sigma), TRF1 (gift from Maria A Blasco), TRF2 (#05-521, Upstate), POT1 (gift from Qin
Yang), 53BP1 (Bethyl Laboratories, A300-272A), MDC1 (gift from Junran Zhang), ATM
(GTX7107, GeneTex), DNA-PKcs (MS-423-P, NeoMarkers), Mre11 (Novus, MB100-142), Nbs1
(Cell Signaling, 3002B), Ku70 (SC-1486, Santa Cruz), H2AX (Upstate, 07-164), H2AX (Upstate,
07-164), ERCC1 (SC-17809, Santa Cruz), RPA2 (Calbiochem, NA18), actin (Clone C4, MPB), βtubulin (Sigma), and BRCA1 (Santa Cruz-6954).

Immunofluorescence
Immunofluorescence

was

performed

with

antibodies:

γH2AX

(1:600,

Upstate

Biotechnology), 53BP1 (1:600, Novus Biologicals NB100-304), RAD51 (1:100, Santa Cruz sc8349), or RPA2 (1:100 Calbiochem, NA18). Cells were grown on coverslips until 70–80%
confluent and irradiated with a dose of either 0.5 Gy (53BP1 and γH2AX) or 8 Gy (RAD51). At
different times post-IR, cells were fixed with 3.7% formaldehyde and 0.2% Triton-X100 for 10 min
at RT. Cells were blocked for 1 h at 37°C with 1% goat serum or BSA in PBS and incubated with
primary antibodies for 1 h at 37°C. Secondary antibody incubations were performed for 1h at
37°C using Alexa- and Cy3-labeled antibodies. Slides were counterstained using DAPI in
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Vectashield (Vector). Fluorescent images were taken using a Nikon 90i upright microscope or
with a confocal microscope Zeiss L510.

X-ray irradiation
This was done using a PANTAK pmc1000 X-ray machine with a 0.1 Cu+ 2.5 AL filter at a
dose rate of 1.1 Gy/min. For immunofluorescence studies cells were irradiated with 0.5 Gy or 8
Gy, and for comet assays cells were given 8 Gy.

Terminal restriction fragment (TRF) analysis
We prepared cells in agarose plugs and carried out TRF analysis as described [249].
Cells were washed with 1X PBS, pelleted by centrifugation, resuspended in 50 μl PBS and
incubated at 50oC for 5 minutes. 50 μl of 2% low-melt agarose/PBS (previously heated at 50oC)
was added and the mixture (100 μl) incubated for 5 minutes at 50oC.This mixture was then
transferred to a disposable plug mold (Bio-Rad #170-3713) and allowed to solidify by cooling at rt
for 5 minutes and then at 4oC for 15 minutes. The plugs were then transferred to eppendorf tubes
and 500 μl of proteinase K buffer (2mg/ml proteinase K) added to the tube, which was incubated
at 4oC overnight. The next day, plugs were washed with TE buffer (4 x 1 hour each). PMSF was
added to the third and fourth washes to inactivate the proteinase K. Samples were then stored at
4oC in TE buffer until digestion. Plugs were washed in water for 1 hour, and then equilibrated for
1 hour in MboI enzyme buffer. Next, the plugs were incubated in 0.3 ml restriction enzyme buffer
containing 50U of MboI enzyme solution overnight at 37oC. Following digestion the plugs were
washed 30 minutes with water and 30 minutes with 0.5X TBE buffer. Finally, pulse-field gel
electrophoresis was performed using 1% low-melt agarose in 0.5X TBE buffer for 23 hours at 6
V/cm2. Following electrophoresis, the gel was denatured 3 x 30 minutes and neutralized 3 x 30
minutes (solutions below). The Whatman TurboBlotter™ system was used to transfer the DNA to
nylon membrane. Finally, DNA was crosslinked to the membrane using the Stratalinker® UV
crosslinker, and treated with a (TTAGGG)n probe.
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TRF solutions
Denaturing solution: 0.5M NaOH, 1.5M NaCl in water
Neutralizing solution: 0.5M Tris-HCl, 1.5M NaCl in water, adjusted to pH 7.0

Quantitative Fluorescence in Situ Hybridization (Q-FISH)
We prepared metaphase stage chromosomal spreads for Q-FISH and hybridized them as
described [250].

Metaphase preparation:
Cells were cultured in 10mm dishes to 70% confluence. Colcemid (Sigma #D1925) was
added to the culture media (100 μl to every 10 ml media) for 4 hours to arrest cells in metaphase.
After collecting the culture media, we washed with 1X PBS (which was also collected), and
collected the trypsinized cells. All the fractions were combined and centrifuged to pellet the cells.
Supernatant was the aspirated to leave ≈1 ml of media + cell pellet, which was resuspended by
gentle flicking. 9 ml of pre-heated (37oC) hypotonic buffer (0.56% KCl) was added then to the cell
suspension, which was incubated in a 37oC water bath to allow hypotonic swelling of the cells. A
small amount (≈3 drops) of fixing solution (3:1 methanol: acetic acid) was added and the cells
were pelleted at 4oC by centrifugation. Cells were kept on ice from this point onwards. After
aspirating the supernatant to leave ≈1ml, the cells were resuspended by gentle flicking and 11ml
fixing solution was added dropwise. The suspension was centrifuged once more to pellet the cells
and fixing solution added in a similar manner. This mixture was stored at -20oC until hybridization.

Metaphase hybridization:
Cells were pelleted, resuspended in 1ml fresh fixing solution, added to microscope slides
and allowed to dry at rt overnight. Next, we washed the slides 3 x 5minutes in 1X PBS, fixed in
4$formaldehyde/PBS and washed 3 x 5 minutes in 1X PBS. Slides were treated with pre-heated
acidified pepsin (below) for 10 minutes at 37oC and washed 3 x 5 minutes in 1X PBS. After a
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second treatment with formaldehyde and PBS washes, the slides were dehydrated by incubating
for 5 minutes each in 70%, 90%, then 100% ethanol and allowed to air dry. Two drops (10 μl
each) of the probe mixture (below) was then added to each slides and a coverslip applied. Slides
were then heated at 80oC for 3 minutes for denaturation, and incubated in a wet chamber away
from light for 2 hours at rt. Following incubation, the slides were washed 2 x 15 minutes in
buffer#1 (below), and then 3 x 5 minutes in buffer#2 (below). Finally, slides were dehydrated in
ethanol as before, air dried and DNA counterstained with DAPI solution. Fluorescent images were
taken using a Nikon 90i upright microscope and intensity of telomere fluorescence analyzed using
the TFL-Telo program (gift from P Lansdorp, Vancouver, Canada) [251]. Images and telomere
fluorescence values were obtained from more than 50 metaphases in all cases.

Q-FISH Solutions
Pepsin solution: 200ml water, 200mg pepsin, 168 μl concentrated HCl (stock 12M).
Probe solution: 2.5μl Tris 1M pH7.4, 21.4μl MgCl2 buffer, 175μl deionized formamide, 5.0μl
telomere probe 25 μg/ml, 12.5μl blocking reagent, 33.6μl distilled water.
PNA telomere probe: TelC-Cy3 (Panagene catalog# F1002-5)
Blocking reagent: 10g Boehringer reagent in 100ml maleic acid buffer pH7.5
Maleic acid buffer: 100 mM maleic acid, 150 mM NaCl pH 7.5
MgCl2 buffer: 25 mM MgCl2, 9mM citric acid, 82 mM Na2HPO4, adjusted to pH 7.0
Buffer #1: 280 ml Formamide, 4 ml Tris 1M pH 7.2, 4 ml BSA (stock of 10% in water), 112 ml
distilled water.
Buffer #2: 0.08% tween-20 in TBS

Viral Transductions
Viral transduction with dominant-negative TRF2, lamin A, lamin C, and shRNAs (shLmna
and shLuciferase). A dominant-negative TRF2 mutant (TRF2∆B∆M) cloned into the pLPC vector
(gift from Titia de Lange, Rockefeller University) along with packaging and envelope plasmids
pUMVC and pCMV-VSV-G (provided by Sheila Stewart, Washington University) were transfected
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in 293T packaging cells using Fugene 6® (Roche Applied Science). Virus-containing media
collected from the 293T cells and used to infect the target cells. For retroviral transductions the
infection was repeated 24 h later. The same procedure was used to introduce lamins A/C into Atype lamins depleted cells. Retroviral vectors for expression of lamins A/C were a gift from Brian
Kennedy (University of Washington, Seattle, WA). GFP was used to monitor the efficiency of
293T transfection and MEF infection. Lentiviral transduction of shRNA sequences cloned into
pLKO was carried out in the same manner, using the packaging plasmid pHR’8.2∆R and the
envelope plasmid pCMV-VSV-G. Infected cells were subjected to immunoblotting after selection
to ensure depletion or overexpression of the target proteins. shLmna and shLuciferase were a gift
from Didier Hodzic (Washington University, St Louis, MO), sh53BP1 was a gift from Barry
Sleckman (Washington University, St Louis, MO). 53BP1 expression plasmid was obtained from
Addgene.

Immuno-FISH
Cells were fixed for 10 min in 3.7% formaldehyde/0.2% Tx-100/PBS at RT, followed by
three washes in PBS. After blocking in 10% BGS/PBS for 1 h, cells were incubated with antiH2AX antibody 1 h at 37°C, washed three times and incubated with secondary antibodies. After
washing extensively in PBS, cells were processed for FISH. Cells were fixed in 3.7%
formaldehyde/PBS for 10 min at RT, washed in PBS, dehydrated in ethanol (70%, 90%, 100%
ethanol, 5min each), and air dried. Hybridization solution containing the cy3-labeled telomeric
probe was added to coverslips, which were heated to 80°C for 10 min, and incubated for 3 h in
the dark at RT. Coverslips were washed twice for 15 min in washing solution, and three times in
PBS. Cells were counterstained with DAPI and coverslips mounted on slides.

CO-FISH
CO-FISH analysis was carried out as described [175]. Briefly, cells were cultured in 20 M
BrdU for 22 h and 0.1 g/ml colcemid was added for the last 4 h to enrich for mitotic cells.
Metaphase stage chromosomal spreads were prepared as for Q-FISH [250]. The slides were
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treated with RNase A (0.5 g ml-1 for 10 min at 37°C), stained with Hoechst 33258 in 2X SSC for
15 min at RT and exposed to 365 nm UV light for 30 min. Exonuclease III (3 U/l) treatment for 20
min at RT was used to digest the BrdU-labeled strands. The slides were then processed as for QFISH but with two different probes added sequentially. Hybridizations were carried out first with
the G-rich probe (labeling the leading strand) followed by the C-rich probe (labeling the lagging
strand).

Histones.
Histones were purified by acid extraction as detailed by Shechter et al [252]. Histone
modifications were detected by immunoblotting using anti-H3K9me3 and anti-H4K20me3
(Upstate).

Telomerase Activity
Telomerase activity was determined using the TeloTAGGG Telomerase PCR ELISA* Kit
(Roche) following manufacturer's instructions.

Comet Assays
Neutral comet assays were performed using CometSlide assay kits (Trevigen). Cells
were irradiated with 8 Gy, and incubated at 37ºC for different periods of time (0, 30, 60, 90, 120
and 150 min) to allow for DNA damage repair. Cells were embedded in agarose, lysed and
subjected to neutral electrophoresis. Before image analysis, cells were stained with ethidium
bromide and visualized under a fluorescence microscope. Single-cell electrophoresis results in a
comet-shaped distribution of DNA. The comet head contains high molecular weight and intact
DNA, and the tail contains the leading ends of migrating fragments. Olive comet moment was
calculated by multiplying the percentage of DNA in the tail by the displacement between the
means of the head and tail distributions, as described 60. We utilized the program CometScore™
Version 1.5 (TriTek) to calculate Olive Comet Moment. A total of 25 to 30 comets were analyzed
per sample in each experiment.
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X-ray irradiation
This was done with a PANTAK pmc1000 X-ray machine with a 0.1 Cu+ 2.5 AL filter at a
dose rate of 1.1 Gy/min. For immunofluorescence studies cells were irradiated with 0.5 Gy or 8
Gy, and for comet assays cells were given 8 Gy.

Homologous recombination assays
Proficiency of HR is monitored by using a chromosomally integrated HR reporter
substrate, DR-GFP, in MCF-7 cells 58. The DR-GFP substrate consists of two tandem GFP
sequences that have been mutated to abrogate expression of GFP and an I-SceI recognition site
in one sequence. Transient expression of the I-SceI produces a DSB at the recognition site.
Repair of this break by intragenic HR with the downstream GFP sequence as the homology
substrate results in restoration of a functional GFP gene. Thus, expression of GFP is readout of
successful HR 58. MCF-7 DR-GFP cells were transfected with an I-SceI expressing plasmid.
After 48 hours, flow cytometry was used to determine the percent of cells expressing GFP as an
indication of successful HR.

Colony formation assays
Clonogenic analysis was performed as described. Briefly, cells were plated in p60 culture
dishes to facilitate formation of 30-40 colonies per plate and allowed to become adherent by
incubating at 37°C for 2-3 hours. Cells were immediately treated with 0, 2, 4, or 6 Gy of ionizing
radiation, and allowed to grow undisturbed for 7-10 days. Colonies were then counted and the
surviving fractions calculated. Colony formation experiments were done three times, with triplicate
samples within each experiment.

Quantitative real time PCR
For chapter 2 Quantitative real-time PCR was carried out on a MyiQ Detection system
(BIO-RAD, California, USA) using Taqman Universal PCR Master Mix (PE Applied Biosystems,
105

MATERIALS & METHODS
California, USA). The cDNA was generated from 1 g of total RNA using Geneamp RNA PCR kit
(PE Applied Biosystems) following manufacturer's instructions. 53BP1 and GAPDH expression
was

determined

using

Taqman

Gene

expression

assays

(Mm00658689_m1

and

Mm99999915_g1, respectively, PE Applied Biosystems). For the analysis, all reactions (in
triplicate) were carried out by amplifying target gene and endogenous controls in the same plate.
Relative quantitative evaluation of target gene was determined by comparing the threshold
cycles.

For chapter 3. Quantitative real-time PCR was performed using the 7900HT Fast RealTime PCR system (Applied Biosystems) with the Taqman® Universal PCR Master Mix (Applied
Biosystems, California, USA). Generation of cDNA was carried out by reverse transcription of 1μg
total RNA using the GeneAmp® RNA PCR kit, also from Applied Biosystems. RAD51, BRCA1
and RPA2 transcripts were detected by TaqMan® Gene Expression Assays (Hs00153418_m1,
Hs01556193_m1, and Hs00358315_m1 respectively). All PCR reactions were done in triplicate
within experiments to amplify endogenous target genes, with 18S controls in the same plate. Data
was analyzed by relative quantitation.

Statistical analysis
A 'two-tailed' Student's t-test, 'two-samples of equal variance' was used to calculate
statistical significance of the observed differences in telomere length. Microsoft Excel v.2001 and
Graphpad Instat v3.05 were used for the calculations. A paired t-test to determine statistical
significance was alternatively used when indicated. In all cases, differences were considered
statistically significant when P<0.05.
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Distribution of the telomeres
To analyze the distribution of the telomeres we have chosen as metric; the shortest
distance from the telomere to the edge of the convex hull [1], see figure 1. The
fluorescent images of the telomere channel have been deconvolved, using in-house
deconvolution software written in MatLab (The Mathworks, Natick, MA, USA). The
MAPPG algorithm is chosen for devolving as described in [2]. The point spread function
(PSF) used is an analytical PSF implemented according to [3]. After deconvolution, four
steps are taken: 1. localization of the telomere signals, 2. computation of the convex hull,
3. computation of the distance transform within the convex hull, 4. extraction of the
distance and intensity of the telomere fluorescent signal. All analyses have been done in
3D, but for clarification we have shown an example of the algorithms in 2D in figure 1.
To determine the position of the telomeres we have used TeloView [4]. This program is
especially designed to locate telomere FISH signals in images of fluorescently labeled
nuclei. It uses a set of image processing algorithms from DIPimage, developed at the
Quantitative Imaging Group (TU-Delft, The Netherlands, http://www.diplib.org) [5].
Both TeloView and DIPimage are implemented in MatLab. localization of the telomere
signal, is performed as described in [6]. In short: after a scale space method, which
enhances the contrast of the signal, a threshold is chosen to segment the telomere signals.
Using the graphical interface of TeloView missed signals can be added or false signals
can be removed. The second step is the calculation of the convex hull [1], which is the
smallest convex volume enclosing all the found telomeres. For the next step we transform
the hull into a distance matrix using the Euclidian Distance Transform (EDT) [7, 8]. The
EDT transforms the binary image (the convex hull image) into an image where the
intensity level of the pixel is the shortest distance from this pixel to the edge of the hull.

ri

Convex hull
Figure 1:

Cartoon showing the distance measure. The red dots represent the telomere signals. The red
line represents the convex hull surrounding the telomeres. For every telomere we measure, ri;
the shortest distance from the surface of the convex hull to the telomere.

Distribution of the telomere intensity
The fourth step is to calculate the integrated intensity of the telomere. The integrated
intensity is proportional to the size of the telomere because the size is proportional to the
amount of fluorochrome that is attached to the telomere and therefore to the telomere
length [9]. We create a binary mask with the watershed algorithm [10] of the image data,

g, convolved with a Gaussian profile with σ = 1 pixel for noise reduction. Now the
telomere coordinates (xn, yn, zn), determined above, tell us which objects in this mask are
telomere regions. Simply integrating intensities in these regions will also give the wrong
answer because background pixels are not excluded from these regions and will bias our
calculations. Our solution is to calculate the integrated intensity in a region of interest
with (xn, yn, zn) as middle point within this mask resulting from the watershed. The region
of interest is a small sphere, with radius r, convolved with a Gaussian profile with width
σ = 1 pixel in the lateral and σ = 3 pixels in the axial direction, which results in an
elongated sphere. We will call this region of interest, which is gray-scale, spheregray and
the region from the watershed, which is binary, we will call mask. The next binary region
with which we work with is spherebin. This is a binary sphere with radius r + 3σ (with
σ = 1 or 3 pixels depending on the direction). Now we define the mean of the grey values
of g at the coordinates where mask has value one and spherebin has value zero as our
background level, b. Our signal image, gsignal, becomes:
g signal = g ( mask ) − b

(1)

We normalize both spheregray and gsignal for their maximum value and calculate their
mean squared difference, εnew, using spheregray as a weighting function:

ε new =

∑ sphere
i

gray ,i

( spheregray ,i − g signal ) 2

∑ sphere

(2)

gray ,i

i

This process starts with r = 1 . First we rename εnew:

ε old = ε new

(3)

Now we grow the region by using r = r + 1 for the next iteration and calculate εnew again.
The iterative process is stopped when

ε new > ε old

(4)

The integrated intensity, In, for the nth telomere is now

I n = ∑ g signal ( spherebin )
In figure 2 we show a flow chart of the algorithm.

(5)

Figure 2:

Flow chart showing the algorithm to calculate the integrated intensity of a telomere
signal. The basic idea is to calculate the integrated intensity in a growing region
of interest until no more intensity is added. The growing is confined by a mask
created by a watershed.
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